key: cord-0789056-3hxgq2ni authors: nan title: 40th International Symposium on Intensive Care & Emergency Medicine 2021 date: 2021-11-15 journal: Crit Care DOI: 10.1186/s13054-021-03769-1 sha: a23428d0f36a96f89790730dd4674adb76789c65 doc_id: 789056 cord_uid: 3hxgq2ni nan Covariates used for this analyses included sex, age, medical history (chronic diagnoses), APACHE III acute physiology score (APS), vasoactive medication and mechanical ventilation and PaO 2 /FiO 2 ratio on ICU admission. Introduction: A personalized approach in sepsis therapy is based on the study of prognostic and predictive risk factors of adverse outcomes. Our objectives were to identify prognostic factors and predictive markers of early and delayed mortality within the first 72 h of hospital stay. Methods: This retrospective study included 136 patients with sepsis (according to the SEPSIS-3 criteria) of pulmonary (37%) and abdominal (63%) etiology at the age from 19 to 81. The anamnestic, clinical and laboratory data were collected. Patients received therapy according to the accepted recommendations. Early mortality was assessed in two time intervals: within the first 72 h of admission and between 4th and 7th day of admission. Delayed mortality was registered after 8th and 15th day. The SPSS program was used for statistical processing. Results: The overall mortality rate was 61%. Within the first 72 h, predictors of deaths (13% of cases) were SOFA score of 8 or more (OR 1.272, p = 0.012, AUC 0.648); lactate level 2 ng/ml or more (OR 1.556, p = 0.025, AUC 0.704); arterial blood pH level 7.22 or less (OR 1.245, p = 0.005, AUC 0.704). Mortality in the period of 4-7 days (18%) was significantly influenced by the level of procalcitonin more than 9 ng/ml on admission (OR 1.199, p = 0.028, AUC 0.604). The prognostic mortality factor for all time periods was the Charlson comorbidity index of more than 4 points (OR 1.515, p = 0.001, AUC 0.721) for early mortality and 3 points (OR 1.498; p = 0.013, AUC 0.666) for delayed mortality (33%). Conclusions: Patients with multiple chronic diseases, severe organ disorders and high microbial load, represent the most vulnerable group in terms of early unfavorable outcomes of the course of sepsis and, apparently, require an immediate start of complex targeted sepsis therapy. Introduction: COVID-19 pandemic has emphatized the need for patients' good orientation, through overflow of critical care induced by surges. Mid-regional proadrenomedullin (ProADM) was suggested as an early biomarker of endothelial damage and organ failures (OF) in sepsis. We aimed to assess its predictive value in COVID-19 patients admitted in ICUs, since endotheliitis is present in COVID-19 sepsis. Methods: Prospective multicentric observational study in 8 ICUs of northern France (July 2020 to February 2021). Main objective was to study association between proADM blood levels at day 1 and day 3 OF, in groups with / without worsening of OF, assessed with SOFA score. Demographic, clinical and biological data were recorded at days 1 and 3 from admission. Univariate and multivariate analysis (logistic regression) were performed. Secondary objectives studied association of proADM levels with need of mechanical ventilation (MV) at day 3 and day 28 mortality. Results: A total of 170 patients were analyzed. Median age was 62; 74.7% were male, and 40.6% presented with cardiovascular comorbidity. Day 28 mortality was 20%. In univariate analysis, worsening of SOFA at day 3 was associated with day 1 proADM levels (1.21 nmol/ml [0.83-1.85] vs 0.89 nmol/mL [0.71-1.12]; p < 0.001), and also with age (p = 0.007), male (p = 0.06), Charlson comorbidity index (p = 0.02), cardiovascular comorbidity (p = 0.02), respiratory rate (p = 0.045) National Early Warning Score (p = 0.01), PaO2/FiO2 ratio (p = 0.06), KDIGO level (p = 0.043), and lymphocytes' count (p = 0.002). In multivariate analysis, there was a trend towards association of SOFA worsening at day 3 with day 1 proADM levels, without reaching significance (OR = 1.94 [0.90-4.15] p = 0.08). Secondary objectives shew in univariate analysis association of day 1 proADM with MV at day 3 (p < 0.001) and day 28 mortality (p = 0.002). Conclusions: Patients' number was calculated from first-wave data, and may have been insufficient to reach significance. ProADM could be a promising biomarker in COVID-19 sepsis, regarding OF. Introduction: Procalcitonin (PCT) and C-reactive protein (CRP) were shown to have value for the detection of secondary infections in critically ill COVID-19 patients. Since the use of immunomodulatory therapy, the value of these biomarkers is unclear. We investigated PCT and CRP kinetics in critically ill COVID-19 patients treated with dexamethasone (DEXA) with or without tocilizumab (TOCI), and assessed the value of these biomarkers to detect secondary infections. Methods: Patients were divided into three groups: no DEXA/no TOCI (D-T-, n = 66), DEXA/no TOCI (D + T-, n = 44), and DEXA + TOCI (D + T + , n = 23). Serial PCT and CRP data were analyzed in the days before and after cessation of DEXA treatment. Furthermore, changes in PCT and CRP kinetics upon occurrence of a secondary infection and accuracy of these biomarkers for the detection of a secondary infection were assessed. Results: Following cessation of DEXA, there was a rebound in PCT and CRP, in particular in the D + T-group. Within both the D + T-and D + T + groups, no significant increase in PCT was observed upon occurrence of a secondary infection compared to patients that did not develop an infection (p = 0.45 and p = 0.29, respectively) ( Fig. 1 ). Although CRP increased in patients of the D + T-group who developed a secondary infection compared to those who did not (p = 0.003), this rise was only apparent from day 2 post-infection onwards. CRP remained completely suppressed in the D + T + group irrespective of the occurrence of a secondary infection. Receiver operating curve analysis of PCT and CRP levels yielded area under the curves of 0.57 and 0.59, respectively, much lower than those obtained in patients not treated with DEXA/TOCI (0.80 and 0.76, respectively). Conclusions: Cessation of dexamethasone treatment in critically ill COVID-19 patients results in a rebound increase in PCT and CRP levels. Immunomodulatory treatment with dexamethasone and tocilizumab nullifies the value of PCT and CRP for detection of secondary infections. . Data of the no secondary infection groups were aligned on the median alignment day, which was day 12 following ICU admission. The light gray line reflects previously reported data of D-T-patients as Reference. Data are presented as geometric mean with 95% confidence intervals. P-values were calculated using mixed-models analyses (time*group interaction factor). P-values in left and right parts of each panel reflect between-group differences in kinetics from day -10 until day 0 and from day 0 until day 10, respectively. Colored diamonds reflect p values of < 0.05 on the individual timepoints, calculated using Sidak's post hoc multiple comparisons tests P020 Computational endotypes of sepsis and septic shock derived from time series data J. Guo Introduction: While sepsis has been characterized through the sepsis-3 consensus criteria as organ dysfunction and dysregulated host response to infection, there remains significant heterogeneity in the prediction, identification, treatment, and outcomes of sepsis and septic shock. This project aims to discover novel subphenotypes of sepsis and septic shock using highly granular time-series data from electronic health records. Methods: From the Philips multicenter eICU database, we calculated sequential organ failure assessment (SOFA) scores and determined infection status by diagnosis and/or positive culture for each adult patient every 5 min. Based on the sepsis-3 criteria met at a timepoint, patients were categorized into four data-driven cohorts, or "statuses" (No Sepsis, Suspected Sepsis [only organ dysfunction], Sepsis, or Septic Shock). 24 clinical and physiological features from 24 to 48 h after ICU admission were used for unsupervised clustering algorithms. Endotypes from clustering were characterized by length of stays (LOS) and hospital discharge outcomes. Results: Clustering analysis identified five distinct groups (Fig. 1) . Cluster 1 contained a large proportion of suspected sepsis patients and 3 contained most septic patients. Clusters 2 and 4 contained the majority of septic shock patients, with 2 having the larger proportion and the overall longest hospital LOS (10.7 days) and largest mortality (35%). Cluster 5 contained nearly all non-septic patients. Clusters with mixes of statuses highlight potential similarities among patients with different sepsis-3 classifications, and the limitations of consensus criteria. Conclusions: Using temporal data with a broader range of features, we identified five distinct endotypes for sepsis and septic shock. The high-frequency time series may allow for a more refined, data-driven method to characterize the evolution of sepsis and stratify patients that may be misidentified through sepsis-3, better informing prediction, detection, and treatment. Identification of computational endotypes. a) Visualization of patient cohorts, or "statuses, " with t-distributed stochastic neighbor embedding (tSNE). The scaled dataset containing 24 clinical and physiological variables was visualized with tSNE, a dimensionality reduction algorithm that probabilistically maps complex high-dimensional data (i.e. 24-dimensional data) to lower dimensions and identifies similar points. Each point represents one 5 min timepoint sample for each patient from 24-48 h after ICU admission. 13,487 timepoints (80% of septic shock timepoints) were randomly sampled for each status. b) Visualization of clusters from K-means (k5) on scaled data overlapped on previous tSNE plot Introduction: Current literature shows that an elevated endotoxin activity is often present in critically ill patients with COVID-19. SARS -CoV 2 spike protein can bind lipopolysaccharide (LPS) and may induce a "cytokine storm". At the same time, the COVID-19 trophism for the ACE2 receptor, which is expressed also in small intestinal enterocytes, may cause a "leak gut" syndrome altering intestinal permeability and promoting the LPS translocation. Our objectives were to evaluate endotoxin activity at the admission in intensive care unit (ICU) and during ICU stay. Methods: We assessed the endotoxin activity assay (EAA), a rapid in vitro diagnostic test that utilizes a specific monoclonal antibody. (Estor, Italy). EAA was measured at the ICU admission (baseline), day 3 and day 7. EAA levels were distinguished in high (EAA > 0.6) and low (EAA < 0.6) endotoxin activity. Blood gas analysis, hemodynamic and breathing pattern parameters were also recorded. We also considered the infections developed during ICU stay and the inflammatory parameters. Results: The figure shows the percentage of patients with high and low EAA, respectively. Of the 40 patients enrolled, 14 had an elevated EAA at the first EAA determination. In this group, the mortality was 57%. In the group of patients without preexisting elevated EAA the mortality was 42%. At baseline, we could not find any correlation between EAA and clinical, ventilatory and hemodynamic characteristics. At day 3 and 7, lactates, presepsin and SOFA score kidney component values were significantly higher in the group of patients with EAA > 0.06. Conclusions: We found that elevated EAA was 35%. This raises the question if a "hypoperfusion", hyperinflammatory state or a direct action of SARS-CoV-2 on small intestinal enterocytes may induce LPS translocation. Further studies are needed to evaluate if high EAA at ICU admission may allow an early recognition of patients with worse ICU outcome. Percentage of patients with EAA high and low, respectively during the 7 days of the study Introduction: Sepsis is common, deadly, and heterogeneous. Prior work proposed clinical sepsis phenotypes at presentation and explored change in phenotype over time. However, little is known about how change in phenotype is associated with outcome. We explored trajectories of phenotypes in the ProCESS trial and the association between change in phenotype and outcome. Methods: We analyzed a cohort of 815 adult sepsis encounters from the ProCESS trial in the Usual Care and EGDT arms that survived in-hospital for at least 72 h post-randomization. We predicted clinical phenotypes at randomization and 72-h post-randomization using Euclidean distance anchored to previously published cluster centroids (α,β,y,∂). We defined core members as ≥ 90% and marginal as < 90% probability of phenotype membership at randomization. We used logistic regression to determine the odds of phenotype transition by phenotype, treatment arm, and membership probability. We explored the relationship between treatment arm, phenotype transition, and in-hospital mortality within the ∂-phenotype. Results: We studied 815 adult sepsis encounters from the ProCESS trial (median age 60, [IQR 50-72]; 56% male, median SOFA at arrival 7, [IQR [4] [5] [6] [7] [8] [9] ) surviving for at least 72 h post-randomization. At presentation, encounters were 36% α-type, 37% β-type, 13% y-type, and 25% ∂-type. Phenotype was unchanged over 72 h in 46% of encounters. Marginal membership was (OR 1.9, 95% CI 1.4-2.6, p < 0.01), but treatment arm was not (OR 0.9 95% CI 0.7-1.2, p = 0.33, Fig. 1A ) associated with increased odds of phenotype transition. Within ∂-type, core membership and EGDT were associated with increased in-hospital mortality (Fig. 1B) . Conclusions: Approximately half of patients changed phenotypes within 72 h and changes were most common in marginal members. Treatment response may differ by phenotype membership probability and is an important area for further research. using K-means clustering. The action space was a 5 × 5 matrix of i.v. fluid and vasopressor doses, including no drug administered then doses divided into quartiles. Awards and penalties were applied, maximizing 90-day patient survival. We compared AI and Clinician policy performance using weighted importance sampling with bootstrapped confidence intervals and determined absolute risk difference in predicted 90-day mortality across patient-and hospitallevel subgroups. Results: We studied 30,687 early sepsis patients (mean age 64 (SD, 16) years; mean SOFA 3.5 (SD, 2.9)). The value of the AI treatment policy was significantly higher than the Clinician policy value (41.9, 95% CI: 41.2-42.7 vs 40.8, 95% CI 39.9-41.6). Predicted risk of 90-day mortality was lower among subgroups with advanced age, higher SOFA scores and non-surgical sepsis treated per the AI policy (Fig. 1A) . The AI policy value exceeded the Clinician policy across all study hospitals and predicted mortality risk difference ranged from 0.01-1.18% (Fig. 1B) . Conclusions: Precision treatment using i.v. fluids and vasopressors is associated with lower 90-day mortality risk among early sepsis patients compared to patients treated per clinician policy, particularly among patients with advanced age, surgical sepsis and severe organ dysfunction. A key tenet of ICU care following emergency laparotomy is administration of appropriate empirical antimicrobials, with prescribing adjustment based on microbiological results. We conducted a quality improvement project with the intention of increasing the frequency of intraoperative peritoneal fluid sampling during emergency laparotomy to see how this would affect postoperative antimicrobial prescribing on the ICU. Methods: A baseline audit showed the frequency of fluid sampling to be 31%. Through collaboration with our surgeons, we encouraged peritoneal fluid sampling for microbiological analysis at the time of emergency laparotomy. Any prescribing changes required from our empirical antibiotics (amoxicillin, metronidazole and gentamicin) were noted. Results: Over an 18-month period, 120 emergency laparotomies were performed on 110 patients. A sample was sent from the peritoneal cavity during 76 operations (63%). Fifty-three samples yielded positive growth. Of these 36 (68%) samples showed antibiotic resistance patterns: 22 (42%) to amoxicillin/co-amoxiclav, 3 (6%) to gentamicin, and 4 cultures (7%) to both. Six (11%) grew candida, one of which was resistant to voriconazole. Of the samples yielding positive growth, a total of 31 (58%) therefore yielded results which would influence a change in prescribing from the hospital's empirical antibiotics. For patients in whom a sample was sent for analysis, a prescription change would therefore be expected in 40%. Our results suggest that sampling peritoneal fluid during emergency laparotomy may alter 40% of antibiotic prescriptions on ICU. Further work is required to understand how this affects patient outcome, but in the absence of these data it seems reasonable to advocate peritoneal fluid sampling during emergency laparotomy to guide subsequent antibiotic decision making on the ICU. Introduction: Older adults (65 years and above) represent 40 to 50% of the ICU population. Unfortunately, critical care evidence-based guidelines for this population are lacking and its representation in randomized control trials (RCTs) is unknown. We aimed to evaluate older adults' participation in critical care RCTs and whether age is considered during analysis. Methods: We conducted a systematic review of systematic reviews in Pubmed, Ovid, Central and Cochcrane, from January 1, 2009, to October 16, 2019. We included critical care systematic reviews and metaanalysis of RCTs based on five ICU topics deemed important for older ICU patients: Acute respiratory distress syndrome, sepsis, nutrition, mobilization and sedation. We collected studies' baseline characteristics, intervention type, and extracted any age information in methods and results. We calculated the proportion of RCTs excluding older adults, with an age central tendency above 65 years, and with outcomes stratified by age and with age-specific subgroup analysis. We used Chi-squared and Kruskal-Wallis tests for comparison between groups. Results: We included 152 RCTs in our systematic review. Older age was an exclusion criterion in 17 (11%) RCTs. Between them, average age was over 65 years for 4 (24%) RCTs and over 70 years for 1 (1%). Those proportions were similar to the 132 trials without age exclusion (p = 0.581). Through the 152 RCTs, outcomes were stratified by age for 5%. Age-specific exploratory subgroup analysis was performed in 5 (3%) trials and 1 RCT reported an interaction between age and intervention, and reported different outcomes in older adults and not for younger ones. Conclusions: Older adults' participation remains underrepresented in intensive care RCTs. The treatment effect differences are not documented. This heightens the need for more age consideration in studies and more studies dedicated for older adults in order to help clinician treat this growing population. Introduction: Increases in distribution volume (Vd) have been suggested to be responsible for subtherapeutic exposure to hydrophilic antibiotics in critically ill patients with sepsis. Until today, no simple and accurate tool has been found to quickly quantify the Vd of antibiotics. Therefore, the primary aim of the present study was to explore the correlation between bioelectrical impedance analysis (BIA) estimated fluid volumes and the Vd of several hydrophilic antibiotics in critically ill patients. Furthermore, the relationship between BIA measurements and the sequential organ failure assessment (SOFA) score and cumulative fluid balance was evaluated. Methods: A prospective observational study was carried out in patients treated with amoxicillin/clavulanic acid, meropenem, piperacillin/tazobactam or vancomycin, admitted to the intensive care unit (ICU) of UZ Leuven. BIA measurement was performed during the same dosing interval as the collection of blood samples to calculate the Vd of the administered antibiotic. Vd was calculated using non-compartmental analysis. Results: In total, 68 patients were included. As shown in Table 1 , significant correlations between Vd and BIA measurements of body water were found for amoxicillin/clavulanic acid (r > 0.78; strong), meropenem (r > 0.43; moderate) and piperacillin/tazobactam (r > 0.51; moderate). When all antibiotics were pooled, correlation remained significant, albeit weak (r > 0.32). No significant correlation was found with the Vd of vancomycin. Patients with an abnormal BIA estimated hydration status appeared more severely ill (i.e., higher SOFA scores). No association with cumulative fluid balance was found. Conclusions: This study demonstrated the existence of a significant positive correlation between BIA assessed fluid status and the Vd of antibiotics at the ICU. However, correlations were not as strong as expected and absolute BIA measurements were not found to be useful in clinical practice. Values are represented as mean ± SD. ECW = extracellular water; ICW = intracellular water; r = correlation coefficient [95% confidence interval]; TBW = total body water. * p < 0.05 given that overall mortality rates may reach values higher than 60% with an attributable mortality of around 40%. Few data are available concerning factors associated with mortality in the context of VREF bacteremia in different centers. The aim of our study was to determine incidence and risk factors associated with VREF bacteremia in an intensive care unit. Methods: A retrospective case-control study was performed in the ICU from January 2014 to December 2020. Cases were defined as septic patients with VREF isolated from a blood culture. VREF was defined as an E. faecium isolate with an MIC of vancomycin ≥ 32 μg/ml by the E-test according to the standards of the Clinical and Laboratory Standards Institute (CLSI). Control patients were randomly drawn from 50 hospitalized patients with vancomycin-susceptible E. faecium (VSEF) isolated from a blood culture. Results: Seventeen case patients and 50 control patients with at least one positive E. faecium blood culture were identified. The demographic and clinical characteristics of the case and control groups were similar, except for mean duration of length of stay (68 ± 9 vs 22 ± 8, p < 0.0001). Mortality did not differ significantly between those with VREF (25%) and those with VSEF (14%) isolates (p = ns). In the univariate analysis, the significant risk factors for VREF bloodstream infections included diabetes mellitus (p = 0.04), end-stage renal disease (p = 0.03), prior exposure to corticosteroids (p = 0.02), prior receipt of vancomycin (p = 0.04) and a prolonged length of stay in ICU (p < 0.01) ( Table 1) . Conclusions: VREF bacteremia in critically ill patients was associated with a poorer outcome. Several risk factors have been identified and they should be considered in infection control practice to prevent VREF infection or colonization and to reduce they duration. Conclusions: MDR ICU-acquired infections are associated with increased daily and total ICU costs. Its prevention may have a considerable impact on healthcare costs. Introduction: Circulating inducible nitric oxide synthase (iNOS) was discovered by us, and it is an accurate and predictive biomarker for the onset of sepsis [1] . Our further discoveries include (a) circulating extracellular microvesicle-associated iNOS (MV-A iNOS) and (b) MV-A iNOS's putative role of causing the cellular damage, vascular leak, and organ dysfunction that are the hallmarks of sepsis by its production of toxic quantities of nitric oxide (NO). We developed a humanized anti-MV-A iNOS monoclonal antibody candidate immunotherapeutic, Asepti-Mab ® , to specifically target circulating MV-A iNOS and to neutralize its harmful effects. Methods: The ability of AseptiMab to inhibit the sepsis cascade and rescue challenged animals from sepsis was tested in three different animal models of sepsis. One model used an LD80 dose of endotoxin (LPS); another model used an LD80 dose of TNF-α, and the third model used an LD80 dose of MV-A iNOS. At 0, 2, or 6 h after the animals were challenged, they were administered either saline (as placebo controls), a low dose of AseptiMab, or a high dose of AseptiMab. Results: In all three animal models of sepsis tested, AseptiMab was effective at rescuing challenged animals from sepsis compared to the saline control groups. The Kaplan-Meier curves conclusively demonstrate that treating the challenged animals with AseptiMab was effective. Up to 80% of the challenged animals can be rescued from sepsis by AseptiMab. Its effectiveness was both time and dose dependent: earlier and higher doses result in improved survival. If a high dose was administered early after the challenge, all the animals could be rescued. In three different animal models of sepsis, AseptiMab effectively treated the sepsis pathology as compared to placebo. Introduction: The use of corticosteroids in the treatment of COVID-19 patients is a matter of debate. The available evidence is uncertain and knowledge on the subject is evolving [1] . The purpose of our observational retrospective study is to evaluate the association between corticosteroid therapy and hospital mortality in COVID-19 positive ICU patients after balancing for possible confounding factors. Methods: A total of 164 COVID-19 positive patients admitted to ICU were included, divided into two groups: 110 patients (Group A) received corticosteroid therapy while 54 (Group B) did not. The daily dose was 8 mg of dexamethasone for a duration of 7 days subsequently reduced until discontinuation. Results: In group A, 28 patients (25%) died while in group B 15 patients (27%). In-hospital mortality was similar between the two groups after adjustment for possible confounding factors (ORadj 1.09, 95% CI 0.78-1.46, p = 0.69). However, corticosteroid exposure was not associated with in-hospital mortality after balancing with the overlapping weight propensity score (adjusted p = 0.2). Conclusions: Corticosteroid treatment did not affect hospital mortality in ICU patients admitted to COVID-19 after balancing confounders. A possible advantage of corticosteroid therapy could be that of reducing ICU admissions when administered to all COVID-19 positive patients with respiratory failure who access the emergency room. Introduction: Secondary bacterial infections in COVID-19 patients are associated with increased mortality [1] . So, several guidelines advocate the use of empirical antibiotics for patients with severe COVID-19. The aim of our study was to evaluate the administration of intravenous immunoglobulins (IVIG) combined with antibiotics to decrease the incidence (I) of superinfections in severe COVID-19 patients mechanically ventilated for ARDS. Methods: We performed a RCT from January 2021 to May 2021. We enrolled 40 patients, 65 ± 12 years old, admitted in a teaching hospital ICU. We randomized 2 groups of 20 patients: A first group receiving broad spectrum antibiotics (ANT) and IVIG and a second group (grp) receiving the same antibiotics and placebo (C). IVIG were administered after the first dose of ANT, at a dose of 0.5 g/kg at flow of 3 ml/kg/h during the first 3 days. We recorded in the two groups: SOFA score Day 1 and Day 7, PaO 2 /FiO 2 day 1 and day 7, duration of mechanical ventilation, ICU stay, hospital length of stay (LOS), the I of secondary bacterial infections at Day 14 and 28-day mortality. Results: In IVIG grp, the mean I of superinfections was less than in the C grp respectively 13.5% vs 26% (Table 1 ). The I of blood stream infections was reduced in IVIG grp comparatively to C grp respectively 8% vs 14.9%. The I of ventilation-associated pneumonia was reduced in IVIG grp comparatively to C grp respectively 20% vs 40%. The I of Gram + infections was reduced in IVIG grp comparatively to C grp respectively19% vs 37%. Mean SOFA score day 7 increased in C grp comparatively to IVIG grp respectively 7.33 ± 0.72 vs 4.45 ± 0.50, p < 0.003. PaO 2 /FiO 2 at day 7 improved in IVIG grp comparatively to C grp respectively 310.8 ± 7 vs 132.4 ± 4.5, p < 0.003. ICU stay (days) was more elevated in C grp comparatively to IVIG grp, respectively 30 ± 6 vs 18 ± 7, p < 0.001. Conclusions: Early initiation of high doses IVIG with ANT decrease the I of superinfections and are associated with better outcome in severe COVID-19 patients. Multivariate regression analysis showed that cardiac disease was the only independent factor associated with significant prolonged QTc. The prevalence of clinically significant QTC prolongation in critically ill patient with SARS-CoV-2 was high and independent of drug used. . The anemic subjects were older than the non-anemic: 63 ± 9.9 years versus 57 ± 11 years. The renal function was more impaired in anemic patients with a clearance of creatinine to 54.66 ml per minute versus 93.62 ml per minute in non-anemic patients. Group 1 patients had more frequently signs of left ventricular (LV) heart failure than group 2 (46% versus 10%). Systolic LV function, however, seemed unaffected by this rate with a mean ejection fraction measured in both groups (43% in group 1 versus 45% in group 2). Diastolic function was more often impaired with higher LV filling pressures in anemic patients (66% versus 30%). The mean length of stay was longer for patients with anemia (12.5 ± 10.1 days versus 7.9 ± 4 days). Conclusions: Anemia at admission for ACS is linked to a pejorative prognosis. A fairly strong relationship is found between low values of hemoglobin and the evolution of patients especially in terms of clinical or latent heart failure. More than two-thirds of the patients were smokers (76.36%). Onequarter were hypertensive (23.63%), nearly half were diabetic (50.9%), and one quarter of our population had dyslipidemia. Coronary inheritance was found in 7.27% of our patients. 16.36% of our patients had high LVFP. Elevation of LVFP was a significant predictor of mortality (p = 0.01) in addition to the occurrence of major cardiovascular events at 6 months of follow-up in our study population (p = 0.001). The study of diastolic function and especially the evaluation of the LVFP at the acute phase of acute coronary syndrome allows to refine the stratification of patients admitted for an acute coronary syndrome and to identify a group of high-risk patients to benefit from more intensive treatment. Evaluation of the association between C-reactive protein levels and coronary lesions severity and mortality in acute coronary syndromes R. More than two-thirds of the patients were smokers (76.36%). Onequarter were hypertensive (23.63%), nearly half were diabetic (50.9%), and one quarter of our population had dyslipidemia. The angiographic findings showed multi-troncular lesions in 60% of group 1 patients versus 26% of the second group. After a multivariate analysis, In-hospital mortality and mortality after 3 months of follow-up were significantly higher in group 1 compared to group 2 (p < 0.0001 and p = 0.019 respectively). Conclusions: Our results demonstrate a strong association between CRP on admission and in-hospital mortality after an ACS, thus suggesting that CRP can be a marker of inflammatory response to myocardial ischemia, providing prognostic information. Introduction: Glycogen phosphorylase BB (GPBB) is a potentially valuable biochemical marker in myocardial ischemia. The aim of our study was to define the kinetics and diagnostic value of GPBB in diagnosing myocardial ischemia using a model of transient ischemia induced by ergometric stress testing. The study included 30 subjects with a positive ergometric test result and coronary artery disease confirmed by coronary angiography (ischemic group), and 15 healthy volunteers with a negative ergometric test result (control group). Plasma GPBB concentration was measured basally at one point, prior to the stress test, and at 9 points after the stress test for the next 6 h. Results: The kinetics of GPBB was significantly different between the ischemic group and the control group (p < 0.001). Analysis of the GPBB dynamics curve in the ischemic group shows a statistically significant difference in comparison with the basal concentration in the measurement taken after 0.5 h, and is also observed in the measurements taken 1 and 1.5 h after ergometric stress testing, while disappearing in the measurement taken after 2 h (Fig. 1) . Analysis of GPBB increase in the ischemic group showed that the median of the highest absolute GPBB concentrations was statistically significantly higher in comparison with the control group (9.34 ng/ml in the ischemic group; 5.90 ng/ ml in the control group). Therefore, a GPBB concentration of 6.775 ng/ ml was determined as the optimal cut-off value for predicting myocardial ischemia, with 83% sensitivity and 87% specificity. Conclusions: GPBB is a valuable biochemical marker in myocardial ischemia, with high sensitivity and specificity. The optimal timeframe for sampling and predicting recent myocardial ischemia by means of determining GPBB concentration is between 0.5 and 1.5 h after the onset of ischemia. (Table) . Dead at 30 days: the former showed lower baseline Hb and arterial pressure, and higher FiO 2 needs. The authors highlight the absence of ICH in patients undergoing SF and the low percentage of major bleeding, compared to that found in the PEITHO study [1] and in the international registry, ICOPER [2] . This could be explained by the non-overlapping of rtPA with hypocoagulation,which explains our high time door to needle. Table. Conclusions: Concordance rates and polar concordance rates were far too low for all devices and CI_CNI. CI_CNI and CI_FT showed acceptable angular bias (< 5°). CI_FT showed acceptable radial limits of agreement within the ± 30° borders, CI_CNI was close. CI_CS had neither an acceptable angular bias nor acceptable limits of agreement. In contrast to CI_CS, CI_¬CNI provides comparable estimates of changes in cardiac index to CI_FT. Acknowledgements: Accuracy and precision for CI_CNI for a smaller data set were presented at ISICEM 2018. SEP group showed a significantly elevated heart rate (p = 0.019), a decreased MAP (p < 0.036) and lower CVP (p < 0.004). PUL and SEP groups showed decreased GEF (p = 0.009) and prolonged ICU stay (p < 0.025). A median split dividing short and long term ICU stays failed to prove a significant difference in mortality among the groups (p < 0.914). The established T3PDS showed a 1.21 × increase for SEP (p = 0.028) and a 1.24 × increase of probability for PUL (p = 0.023) to die with higher scores. The T3PDS cut-off analysis showed a probability of death increase with > 6.4 pts (AUC: 0.86 ± 0.1, 95%, p = 0.021). The study shows that the commonly used algorithms in achieving hemodynamic stability provide a solid therapeutic concept irrespective of the underlying cause. In case of septic patients we recommend early and continuous monitoring in case of typical signs of tachycardia, hypotension and high CVP. We advise to consider a prolonged stay for septic patients. The T3PDS has to be validated in a larger patient population. [1] . Studies have assessed for ischemic complications of radial artery cannulation [2] , but there is lack of evidence using ultrasound to determine whether limbs at risk of ischemia are being cannulated and for the presence of collateral ulnar flows. The objective was to assess collateral ulnar flow, compare flow and size of radial and ulnar arteries and to detect limbs at risk of distal ischemia using ultrasound in ICU patients. A prospective cohort study was conducted at William Harvey Hospital ICU, UK. From 1/12/2019-9/3/2020, data were collected from patients on ICU. Vascular probe ultrasound was used to determine the size of radial and ulnar arteries bilaterally, presence of adequate color flow and flow velocity through each vessel. Complications associated with the arterial line were noted. Results: A total of 53 patients were included. A total of 34 patients had radial arterial lines in situ. The mean longitudinal diameter for radial and ulnar arteries was 0.23 cm and 0.22 cm, respectively, both larger than the internal diameter of cannulae used (0.8 mm). Eighteen patients had at least one at risk limb (≥ 1 artery with anything less than 'good' visual flow on color Doppler). 50% had an arterial line present in at risk limb. There were no major complications noted. Conclusions: 24% of patients had at least one 'at risk' limb with 15% of upper limbs having moderate/poor collateral ulnar flow. This indicates a significant proportion of patients on ICU at risk of digital ischemia and the need for assessment of radial and ulnar arterial size and flow before cannulation. Introduction: Cardiac involvement of COVID-19 is not fully explored in intubated ICU-patients although findings suggest a link to worsened outcome. To the best of our knowledge there are no prospective studies evaluating changes over time using ultrasound. We aimed to evaluate right ventricular (RV) and left ventricular (LV) systolic function, and resolution of pulmonary hypertension (PH). We performed a sub-study of a prospective RCT at a Swedish ICU (NO SARS-COVID) examining the effects of inhaled nitric oxide (iNO) on the recovery of ICU-patients treated for COVID-19. Adult patients were included within 72 h of intubation and evaluated by echocardiography at study inclusion and at follow-up 3-5 days after randomization. Results: Thirty-nine patients were included, 33 completed follow-up (Table 1 ). At inclusion, eight patients had RV dysfunction evaluated by tricuspid annular plane systolic excursion (TAPSE) and eight evaluated by right global longitudinal strain (RVGLS). None had LV systolic dysfunction evaluated by ejection fraction (EF), but 10 evaluated by global longitudinal strain (GLS). Thirty-two patients had signs of PH, median (IQR) mean pulmonary artery pressure (MPAP) 35.3 mmHg (28.0-46.8). At follow-up, none had RV failure evaluated by TAPSE in the control group and 1 in the iNO group, but 3 in the control group and 5 in the iNO group evaluated by RVGLS. No patients in either group had LV systolic failure at follow up evaluated by EF, but GLS unmasked dysfunction in 4 patients in the control group and 1 in the iNO group. All patients in the control group had signs of PH, MPAP 56 (38-62) and 17 in the iNO group, MPAP 39 mmHg (28-54). Conclusions: As expected, PH was frequently seen in our cohort of intubated patients with COVID-19 and did not resolve after administration of iNO. We encourage use of strain analysis to assess chamber function more accurately beside conventional echocardiography parameters to unmask subclinical cardiac dysfunction. For the detection of catheter tip malposition, TTE through the subcostal acoustic window has shown to be by far the most accurate method providing 96% sensitivity, 98% specificity and 96% diagnostic accuracy if compared with the apical four-chamber view TTE or CXR. Concordance with TEE was 94% (p < 0.001). The close concordance between TTE through the subcostal acoustic window and TEE justifies the use of ultrasounds as a standard technique to ensure the correct positioning of the catheter tip after central venous catheter cannulation, in order to optimize use of hospital resources and minimize radiation. CXR will be necessary when sonographic examination is impossible to perform by technical limitations. Introduction: Measuring cardiac output is essential when treating critically ill patients and patients undergoing high-risk surgery [1] . Pulmonary artery catheter is considered as the gold standard for measuring cardiac output, but it is invasive and can be harmful to the patients [2] . Less invasive monitors have recently been developed. We compared the accuracy, precision and trending ability of non-invasive bioreactance-based Starling SV and mini-invasive pulse power device LiDCOrapid to bolus thermodilution technique with pulmonary artery catheter (TDCO) when measuring cardiac index (CI) in the setting of cardiac surgery with cardiopulmonary bypass (CPB). Methods: Twenty patients undergoing cardiac surgery with CPB were monitored with Starling SV, LiDCOrapid and TDCO intraoperatively in the OR and postoperatively in the ICU resulting in simultaneous 513 CI measurements. We used the Bland-Altman method to investigate the agreement between the devices and four-quadrant plots with error grids to assess the trending ability. The agreement between TDCO and Starling SV was associated with a bias of 0.43 l/min/m 2 (95% confidence interval, 95% CI, 0.37 to 0.50), wide limits of agreement (LOA, -1.07 to 1.94 L/min/m 2 ) and a percentage error (PE) of 66.3%. (Fig. 1a) The agreement between TDCO and LiDCOrapid was associated with a bias of 0.22 l/min/m 2 (95% CI 0.16-0.27), wide LOA (-0.93 to 1.43 l/min/m 2 ) and a PE of 53.2% (Fig. 1B) . Trending ability was not acceptable, since with Starling SV only 26% and with LiDCOrapid 39% of measurements changed in the same direction to the same extent as with TDCO. Conclusions: CI measurements with bioreactance-based Starling SV and pulse power device LiDCOrapid were not interchangeable with TDCO, and their ability to track changes in CI was poor. These results do not support their use in monitoring CI reliably during and after cardiac surgery with CPB. Introduction: The effect of low central venous pressure (CVP) or goal-directed fluid therapy (GDT) during major liver resection on organ perfusion is undefined. The present study aimed to assess sublingual and intestinal organ microcirculation during low CVP or GDT fluid management in patients undergoing major liver resection. Methods: In this single-center, surgeon and patient-blinded, randomized controlled trial, patients undergoing major open liver resections (≥ 3 segments) were randomized to receive either GDT or low-CVP. As a substudy of this trial, sublingual and intestinal microcirculation were assessed using the handheld video microscope, IDF imaging. The sublingual and intestinal microcirculations were measured after skin incision (T0) and before skin closure (T1); 24 h after surgery sublingual microcirculation was measured again (T2). Patients' baseline characteristics, intra-operative parameters and outcomes were analyzed. Results: A total of 38 patients were included for analysis, 18 in the GDT group and 20 in the low-CVP group. Sublingual microcirculation in the GDT group showed a significant decrease in total vessel density 24 h after surgery, and a significant decrease in intestinal microcirculatory density at the end of surgery. The GDT group showed a more positive fluid balance intraoperatively when compared to the low-CVP group. No differences in sublingual and intestinal microcirculation were found in the low-CVP group. Patient outcomes showed no differences between the groups. Conclusions: Perioperative monitoring of organ microcirculation revealed altered intestinal and sublingual microcirculation in the GDT group, whereas the low-CVP group showed no changes. Outcome of patients were similar between the study groups, suggesting recovery of the microcirculation in the GDT group over time. Monitoring of the organ microcirculation is a potential measure to control and evaluate the effects of fluid therapy on the perfusion. Fluid responsiveness assessment by passive leg raising and mini-fluid challenge in major surgery, a prospective study L. Introduction: Intravenous (i.v.) fluid resuscitation is a central component of septic shock resuscitation but in excess is associated with adverse effects. Dynamic measurement of stroke volume (SV) following a fluid challenge is a safe and feasible method of rapidly predicting the effectiveness of fluid-induced augmentation of cardiac output. We have previously shown that SV guided dynamic assessment could alter the amount of i.v. fluid administered to patients with septic shock and improve patient outcomes. We sought to evaluate the timing of the initiation of dynamic methods using a large number of patients within the Premier dataset. We used the 2013-2019 Premier Hospital Discharge database to analyze the timing of initiating dynamic methods to guide fluid administration in 1,123 patients with severe sepsis and septic shock who were admitted to an ICU from the ER. Patients who received dynamic monitoring initiated days 1-2 were compared to those who received dynamic monitoring on days 3 and later. The analysis set consisted of 1123 discharges from 19 hospitals. The mean patient age was 68.6 years of age and 42.2% were female. There was no significant difference in demographics or organ failures ( Fig. 1) . Notably, patients who received monitoring on days 1-2 exhibited a decreased ICU length of stay (4.5 vs 10.7 days, p < 0.0001) and need for vasopressors (2.5% vs 17.4%, p < 0.0001) and lower risk of death (27% vs 40%, p = 0.001) compared with patients who had monitoring started on Days 3 + ( Fig. 1 ). The present results suggest that timing of resuscitation efforts is critically important, as patients who received earlier dynamic monitoring exhibited improved outcomes. Introduction: Values of SVV higher than 13% in some cases predict fluid responsiveness. SVV is derived from pulse contour analysis of arterial blood pressure curve. The uncalibrated "Flotrac"-device (Edward Lifesciences) estimates SV (and so SVV) with an unpublished formula. In contrast to the PiCCO device (Pulsion), where SV (and so SVV) is derived from pulse contour analysis calibrated to individual patient. But also with fingerplethysmographically ("Clearsight", Edward Lifesciences) derived blood pressure signals SVV can be obtained (using uncalibrated pulse contour analysis). Methods: We compared 256 simultaneously derived measurements of SVV from Clearsight (SVV_CS), Flotrac (SVV_FT) and PiCCO (SVV_ PiCCO) as gold-standard, directly after calibration of the PiCCO-device in 32 ICU patients. Primary endpoint: Concordance of the measurements within the categories " < 9%", "9-13%" and " > 13%". Statistics: Microsoft Excel, IBM SPSS 25. Results: n = 32 (m = 22, f = 10; age 69 ± 13), APACHE II 29 ± 6, vasopressors 175/256. SVV_PiCCO could not be derived in 22/256 (8.8%) pairs of measurement, whereas Clearsight-and Flotrac-signals always could be obtained. SVV_PiCCO was higher (13 ± 7.6%) than SVV_FT (9 ± 4.9%) and SVV_CS (10 ± 5.4%). Classification within the categories " < 9%", "9-13%" and " > 13%" for SVV_FT and Introduction: The prediction of fluid responsiveness is required to avoid unnecessary volume expansion in patients with ARDS. So the objective of our study was to assess whether hemodynamic changes during a short elevation of PEEP would predict fluid responsiveness in patients with ARDS. Methods: This prospective observational study conducted from april 2018 to april 2020 enrolled 30 patients presenting a mild ARDS according the classification of Berlin.They were 60 ± 10 years old and were submitted to a protective ventilation with PEEP 8, with the use of "tidal volume challenge" to improve the reliability of pulse pressure variation (PPV) [1] . A PEEP challenge was performed in patients hemodynamically stable, and consisted of increasing PEEP progressively from 8 cmH 2 O to 12 cmH 2 O with a time of ten minutes to reach 12 cmH 2 O. We recorded continuously, systolic pressure variation (SPV), mean arterial pressure (MAP) and PPV from the arterial wave line. We measured also cardiac index (CI) with echocardiography. Central venous pressure (CVP), PPV, SPV, MAP, and CI, were evaluated at PEEP 8 and at PEEP 12. Results: Statistical analysis was performed using student's t test. Results were expressed as mean ± std deviation. We observed finally that PEEP challenge from PEEP 8 (control) increases PPV, SPV, CVP and decreases MAP (Fig. 1 Introduction: Testing preload responsiveness in patients with acute respiratory distress syndrome (ARDS) during prone position without requiring cardiac index (CI) measurements has been poorly investigated [1, 2] . Our study aimed to evaluate the ability of pulse pressure variation (PPV) and its changes during a 1-min tidal volume (TV) challenge (TVC) to assess preload responsiveness in ARDS patients under prone position. Methods: Patients with ARDS ventilated with a 6 ml/kg TV under prone position were prospectively included. By using a pulse contour analysis monitor, we measured PPV and changes in CI during a Trendelenburg maneuver (ΔCITREND). After transiently increasing TV to 8 ml/kg, we measured first absolute changes in PPV during TVC (ΔPPV TVC6-8) and then changes in CI during end-expiratory occlusion (EEO) (ΔCI EEO8). Preload responsiveness was defined by both ΔCITREND ≥ 8% [1] and ΔCI EEO8 ≥ 5% [2] . Preload unresponsiveness was defined by both ΔCITREND < 8% and ΔCI EEO8 < 5%. Results: Eight-four cases were analyzed in 58 patients (65 ± 11 y.o.) under prone position for 11 (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) hours. The mean arterial pressure was 82 (75-90) mmHg (under norepinephrine in 83% cases). The driving pressure was 12 (10-18) cmH 2 O, the respiratory system compliance was 32 (21-40) ml/cmH 2 O and the ratio of partial pressure arterial oxygen and fraction of inspired oxygen was 104 ± 27 mmHg. Forty-two cases were classified as preload responders. The baseline PPV predicted preload responsiveness with an area under the receiver operating characteristic curve (AUROC) of 0.85 ± 0.04 (threshold 5%; sensitivity: 74%, specificity: 79%). The ΔPPV TVC6-8 predicted preload responsiveness with an AUROC of 0.94 ± 0.03 (threshold 2%; sensitivity: 98%, specificity: 88%) (p = 0.03 vs. PPV). In patients with ARDS under protective ventilation during prone position, the changes in PPV during a 1-min TVC could reliably assess preload responsiveness without the need of CI measurements. continuous-renal-replacement-therapy before ICUCA (OR: 5.9; 95%CI: 1.7-20.8). Interestingly, HCO 3 − levels > 21 mmol/l in combination with cardiac comorbidities were associated with a higher mortality-risk (HCO 3 − < 21 mmol/l: 13%; 21-26 mmol/l: 45%; > 26 mmol/l: 42%) / SOFA ≥ 2 (HCO 3 − < 21 mmol/l: 8%; 21-26 mmol/l: 36%; > 26 mmol/l: 33%). Hospital-mortality was 78% (n = 89). 1-year-survival-rate was 10% (95%CI: 5.5-17.7), survival with a good neurological (CPC1-2) outcome was 6.1% (95%CI: 2.5-12.2). Conclusions: ICUCA is a rare but serious complication in the ICU. Further research should concentrate on identifying early predictors of survival, such as HCO 3 − levels, and subsequently on the prevention of ICUCA. Introduction: The management of postcardiac arrest (CA) patients may be ineffective or even harmful due to heterogeneity of treatment effects. Heterogeneity could be mitigated if undifferentiated CA populations could be resolved into biologically more uniform subphenotypes. We hypothesized that computational analysis of physiological time series (PTS) data recorded in the first 3 days of intensive care would uncover latent, clinically meaningful subphenotypes. Methods: Patients admitted to ICU after CA were identified in the multi-center Philips eICU database, and PTS signals recorded in first 72 h after ICU admission were extracted (heart rate, blood pressure, pulse oximetry, and respiratory rate). Temporal, frequency, and information theory-based PTS features were derived and analyzed using consensus clustering, an unsupervised machine learning approach which reconciles clustering information about the same dataset coming from different sources or from different runs of the same algorithm. Results: From 2,095 CA patients in eICU we derived 91 PTS features, from which 3 unique clusters were identified, each associated with a distinct clinical outcome distribution, leading to the designation of low, intermediate, and high risk subphenotypes (respectively clusters 1, 3 and 2 in Fig. 1 ). Clusters were differentiable by PTS features but not by demographic and/or other clinical characteristics (Fig. 1C ). Conclusions: Among CA patients admitted to ICU, unsupervised learning applied to data routinely recorded in the ICU indicates the presence distinct physiological subphenotypes associated with specific outcome probabilities. These subphenotypes were latent, as they could be differentiated on the basis of clinical features. Introduction: Targeted temperature management (TTM) is associated with higher odds of neurological recovery in comatose survivors of cardiac arrest. However, the efficacy of TTM is not consistently observed, possibly due to heterogeneity of treatment effects. The aim of this study is to determine if models leveraging data available in the first 6 h after ICU admission (hyperacute phase) are predictive of shortterm outcomes after TTM. Methods: Adult patients receiving TTM after cardiac arrest were selected from a multicenter ICU database. Predictive features were extracted from clinical, physiologic, and laboratory data available in the hyperacute phase. Primary endpoints were survival and favorable neurological outcome, determined as a motor Glasgow Coma Scale (mGCS) of 6 upon discharge. Three machine learning algorithms were trained: GLM, random forest (RF), and gradient boosting (XGboost). Models with optimal features from forward selection were tenfold cross-validated and resampled 10 times. Results: Data were available on 969 cardiac arrest patients who received TTM, of whom 491 survived and 237 had favorable neurological discharge. The GLM performed best, with an AUROC of 0.702 ± 0.029, sensitivity 0.621 ± 0.116, and specificity 0.666 ± 0.117 for the prediction of survival and an AUROC of 0.678 ± 0.041, sensitivity 0.691 ± 0.149, and specificity 0.565 ± 0.137 for the prediction of favorable neurological function. Highly ranked features predictive of survival and favorable neurological outcome included male gender, higher respiratory rate, and greater systolic blood pressure range. Conclusions: In patients receiving TTM after cardiac arrest, short-term outcomes can be predicted with data routinely collected in the first 6 h after ICU admission. Ongoing model iterations will integrate novel features and include external validation. Hyperacute prediction could increase the effectiveness of clinical decision-making in the post-cardiac arrest setting. Research has demonstrated that optimal CPR efforts not only require technical skills and knowledge, but also non-technical skills (NTS) such as leadership, teamwork, and task management [1] . This prospective observational study analyses the NTS of MMTs during OHCA, using the validated Team Emergency Assessment Measure (TEAM). Also, the correlation between NTS and outcome is researched. Methods: Adult patients who suffered from an OHCA between July 2016, and June 2018, and treated by MMT from the University Hospital Leuven, were eligible for the study. Resuscitations were video recorded by the team leader using a GoPro body camera. The recordings were independently scored by 2 ACLS-certified emergency physicians. Results: A total 114 OHCAs were analyzed. The mean TEAM score was 34.4/44. The mean item score was 3.1/4; 'effective team communication' scored the lowest (2.4), while 'acting with composure/control' and 'following of approved standards/guidelines' scored the highest (3.4). The average theme scores were 2.9 for 'Leadership' , 3.1 for 'Teamwork' and 3.3 for 'Task management' . 'Leadership' was rated significantly lower than 'Teamwork' (p = 0.004) and 'Task management' (p < 0.001). No significant correlation was found between TEAM and ROSC (p = 0.574) or one month survival (p = 0.225). Conclusions: Although the TEAM score was good, large differences were observed. Task management was scored high, while leadership and team communication received lower scores. Despite the growing evidence, in this study no correlation was found between NTS and survival. Introduction of a NTS program into ACLS courses, with a focus on leadership and communication, might improve NTS. A constructive feedback platform can encourage post-event 'hot debriefs' to identify points of improvement. TEAM can be a helpful tool to achieve this. In pediatric out-of-hospital cardiac arrest (OHCA), as asphyxia cardiac arrest is more common than cardiac arrest from a primary cardiac event, effective ventilation is crucial during CPR. We hypothesized that dispatcher-assisted conventional CPR would be better than dispatcher-assisted compression-only CPR as a bystander CPR instruction. Methods: We analyzed the records of 8172 children who received bystander dispatcher-assisted CPR after OHCA using the All-Japan Utstein-style registry for 13 years (2005-2017). Patients were divided into conventional CPR (n = 3077) and compression-only CPR (n = 5095) groups. The primary study endpoint was 1-month neurological intact survival, defined as a Cerebral Performance Categories score of 1-2 (CPC 1-2). Secondary study endpoints were 1-month survival and prehospital return of spontaneous circulation (ROSC). Results: The CPC 1-2 rate was significantly higher in the conventional CPR group than in the compression-only CPR group (before propensity score [ Conclusions: Dispatcher-assisted conventional CPR may be preferable to dispatcher-assisted compression-only CPR as an optimal CPR instruction for coaching callers to perform bystander CPR. Introduction: In case of prolonged out-of-hospital cardiac arrest (OHCA), the patient is commonly transported to hospital using mechanical CPR and ventilation with 100% oxygen. Despite this many patients arriving to hospital have severe hypercapnia and hypoxia. One possible reason for this is impaired ventilation due to the counterpressure caused by the continuous chest compressions. We hypothesized that a compression/ventilation ratio of 30:2 would provide better ventilation and gas exchange compared to continuous compressions over ventilation during prolonged CPR. Methods: We randomized 30 anesthetized domestic swine (weight approximately 50 kg) with electrically induced ventricular fibrillation to continuous or intermittent chest compressions and bag-valvemask ventilation with 100% FiO 2 . We started CPR after a 5-min no-flow period and continued it up to 40 min from the induction of VF. Chest compressions were performed with a mechanical chest compression device (LUCAS ® , Stryker Medical). We collected arterial blood gas samples every 5 min during CPR. We compared PaO 2 , PaCO 2 and lactate over time using a mixed linear model. Results: There were no statistically significant differences in PaO 2 (p = 0.40), PaCO 2 (p = 0.79) or lactate (p = 0.37) between continuous and 30:2 compression/ventilation (Fig. 1) . The significance values for the interaction between compression/ventilation group and time were as follows: p = 0.43 for PaO 2 ; p = 0.37 for PaCO 2 ; p = 0.55 for lactate. Conclusions: Prolonged CPR with mechanical chest compressions performed either continuously or with a 30:2 compression/ventilation ratio resulted in similar arterial levels of oxygen, carbon dioxide and lactate. The annual incidence of in-hospital cardiac arrest (ihCA) in Europe ranges between 1.5-2.8/1000 admissions and is associated with high mortality. Up to 80% of ihCA are preceded by easily identifiable signs of clinical deterioration. A Rapid Response Team (RRT) may help to minimize in-hospital morbidity and mortality. However, the RRT activation is delayed or even not activated in 30-78% of patients who might benefit. A Modified Early Warning Score (MEWS) may allow the early detection of these patients with a high mortality risk, prevent ihCA and allow prompt admission to the ICU. Methods: Retrospective, observational, single center study. Data were collected from the RRT activation registries and hospital clinical database. We included all adult RRT activations between January 2018 and December 2020. Clinical signs during the 24 h before the index activation were collected for patients with ihCA. Results: During the study period there were 144 RRT adult activations, including 54 ihCA. Of these, 9 were excluded due to incomplete data. The 45 ihCA remaining patients were old (mean age 75 ± 15 years) and 28 (62%) were male. Patients with a RRT activation for another cause were younger (63 ± 22 years), and 37 (41%) were male, p < 0.001. The MEWS score was elevated 24 h before ihCA patients in 67% of patients. In 14 patients (31%), there were criteria for the activation of the RRT (MEWS ≥ 4). The most common initial rhythm was assistole (91%); the median time of the cardiopulmonary resuscitation attempt was 18 min [10-25] , but only 7% of patients had return of spontaneous circulation. The ihCA hospital mortality was 93%. On opposite, the other RRT activations, without ihCA, had a mortality rate of only 8% (Table 1) . Conclusions: During the study, period ihCA had a very high mortality rate. Early recognition of signs of clinical deterioration (using the MEWS score) and prompt activation of a RRT may help to prevent ihCA and decrease mortality. Introduction: Medical simulation is both a means of assessment and training. The aim of this study is to study the medium-term educational contribution of high-fidelity simulator compared to conventional training. A population of anesthesist-intensive care and emergency medicine residents; already familiar with simulation for clinical situations other than cardiocirculatory arrest at the IMS simulation center; were included in the study and divided into two groups. A group "ACC" for Cardio-Circulatory Arrest, which was specifically trained on a simulator on this topic. A control group "C" who had only theoretical training. Each of the residents was assessed on their management of critical situation: refractory ventricular fibrillation (VF) at six weeks and then at 6 months from the date of initial practical training for the ACC group. The scenario was the same for all residents. Results: Twenty residents in intensive care anesthesia and 10 in emergency medicine were included with 15 residents per group (10 anesthesia-intensive care and 5 emergency medicine). The scores obtained by ACC group were significantly higher than those of the C group either at 6 weeks or at 6 months, and also for the "diagnosis" and "compliance with the algorithm" subgroups. There is no significant improvement in scores between the different assessment times for the ACC group. On the other hand, for group C there is a significant improvement in grades at 6 months (T1) compared to grades obtained at 6 weeks. The ratings of participants during the study were positive. Conclusions: This study confirms the short and medium term educational benefit of simulator training versus traditional training. The use of simulation allows knowledge retention for up to 1 year after the initial practical training phase. [1, 2] . In the literature, there are many examples of the artificial intelligence (AI) efficiency, specially, in intensive care unit (ICU), in the prediction, in database creation, in the therapeutic help [3] [4] [5] . In some case, it could be fastidious to create a database, so we developed an automatized extraction tool, based on a text mining approach. Methods: We used unstructured data, including computerized hospital report (CHR), from two centers. Successive samples of CHR have been drawn randomly and annotated, to reach a total of 143 annotated CHR. We incrementally increased the size of samples. If the concordance rate exceeded or if it was equal to 90%, for every interest variable, we considered the sample validated. Once the data are extracted, we performed a clustering, to identify patterns in the CHR, a missing value and a miss extraction value analysis. Results: After the full development and the training of our tool, we can extract 51 variables, with a mean accuracy of 92.75%, with the better performance in admission biology, patient characteristics, and the deceased status (Fig. 1 ). An analysis on algorithms errors showed that the main extractions errors were attributable to the complexity context and to the complexity variables (36% both). The most missing values were found in the biology variables (59.27%). The clustering results showed two group of CHR, differing for death, witness presence, multi-organ failure, status epilepticus and Glasgow scale. We developed a reliable extraction tool, fully automated and adaptative, able to extract hundreds of data in seconds (0.27 s for one CHR and 137.6 s for 504 CHR). It is useful for data base creation, by is simplicity and its quick use. Introduction: Preeclampsia (PE) is the combination of pregnancyinduced hypertension (≥ 140/90 mmHg) and proteinuria greater than or equal to 300 mg per 24 h above 20 weeks of amenorrhea. It usually disappears immediately after delivery in 24 to 48 h. However, it can persist after placental evacuation and up to 6 weeks after delivery. Hence the importance of early diagnosis of persistent preeclampsia (PPE) postpartum and detect signs of severity, in order to establish adequate driving in time. Methods: We led a retrospective study of 547 cases of preeclampsia collected in the Gynecology and Obstetrics department of the Ibn Rochd Hospital over a period of 3 years. Two groups were identified. Group 1 (n = 504) included patients with preeclampsia immediately disappearing in the postpartum and a group 2 (n = 43) of patients with PPE. We followed them before and after delivery. Results: Persistent preeclampsia represented 8%. Mean age of our patients was 29.15 ± 15.13 years. Factors related to the persistence of preeclampsia were mainly pauciparity in 61%, history of PE in 4.7%, gestational age < 36 weeks in 56%, severe preeclampsia in 14.7%, hypotrophy in 6% and eclampsia in 2%, and massive 24 h proteinuria ≥ 3 mg/24 h in 60% (all p were 160/110 mmHg in 20.4%, a SBP > 170 mmHg in 13%, a DBP > 110 mmHg in 9%. Edema was present in 70% of cases and was generalized in 9% of cases. The vaginal delivery was done in 44% of cases, Caesarean section was recommended in 56% of cases. Conservative treatment was adopted in 22% of cases; 15.05% required immediate use of intravenous antihypertensive treatments. Crit Care 2021, 25(Suppl 1):383 Conclusions: Preeclampsia is still common in developing countries. It remains a major cause of maternal and fetal morbidity and mortality. Our study confirms the seriousness of persistent pre-eclampsia, which carries a high risk of maternal complications (eclampsia, acute renal failure, cytolysis, etc.) and maternal mortality, which can be reduced at the cost of a better detection and treatment policy. Introduction: The objective of this case description is to create awareness among pediatric intensivists about the diagnostic pitfalls regarding Multisystem Inflammatory Syndrome in Children (MIS-C) and its differential diagnosis. Methods: By means of two case descriptions, we illustrate and reflect on the pitfalls that led to both under-and overdiagnosis of MIS-C. Results: Brief patient descriptions are presented in Table 1 . The 3-yearold patient was misdiagnosed for MIS-C and turned out to have a perforated appendicitis with peritonitis. The suspicion of MIS-C was based on clinical symptoms in combination with the elevated NT-pro-BNP, which is often seen in MIS-C. However, elevated cardiac biomarkers as NT-pro-BNP and Troponin-T may also be caused by non-cardiac causes, like sepsis, shock and ARDS [1] . The combination of fever, gastrointestinal symptoms and hypotension that were present in this girl, are often presenting symptoms of patients with MIS-C. However, they are not specific and are seen in a range of other diagnoses as well. The 8-year-old girl, with the same symptoms of fever, gastrointestinal symptoms and hypotension, was initially diagnosed for acute appendicitis, but turned out to have MIS-C with left ventricular failure. While no clear symptom or biomarker can distinguish between MIS-C and its differential diagnosis, the presence of conjunctivitis, skin rash and/or coronary dilatation on echocardiography are suggestive for MIS-C, while blood cultures can help to differentiate MIS-C from septic shock / toxic shock syndrome. Conclusions: Intensivists have to be aware of the existence of MIS-C and the pitfalls of its broad clinical and biochemical abnormalities. Accurate physical examination, including examination for conjunctivitis and rash, echocardiography and blood culture results can be supportive to make the correct diagnosis and to start the right treatment, right on time! Consent to publish was obtained from parents of both patients. Introduction: Acute intoxications in children are an important problem in pediatric practice due to their frequency and severity [1] . To detect as early as possible the type of intoxication in the child, the time interval since the intoxication occurred and to act promptly and correctly in providing first aid and treatment. Introduction: In the Emergency Department (ED) rapid triage and timely interventions are critical for high-risk patients. One of the main ED priorities is to quickly identify those who will need hospital admission. This study evaluates the performance of a simple logistic model on its ability to predict whether a patient visiting the ED will subsequently be admitted to the hospital or not, based on initial ED patients' data retrieved from the Biochemistry and Hematology Laboratories. Our aim is to find an algorithm using ML techniques to assist clinical decision-making in the emergency setting. [3] operational support. Innovative drones for mapping and logistical operations, autonomous vehicles with 3D and thermal camera, portable control center and resilient communications structure have been introduced in USAR procedures for increase the efficiency in the disaster response. It has been designed a scenario involving a simulated earthquake, with an area of collapsed buildings. FASTER tools have been testing in it, to confirm their usability in realistic, and hazardous environment (Fig. 1) . User feedback and KPI has been collected regarding the functionality and effectiveness of the FASTER tools. The initial assessment of the disaster area has been improved with the results obtained within the UAVs aerial imagery. Risky maneuvers have also been decreased by performing the 3D inspection, thermal vision and agile communications. Conclusions: The tools tested have given a major step forward in improving the work dynamics of the health emergency and firefighter professionals [4] . The planning process and the management of the disaster have been facilitated and enhanced using innovative technologies. Professional methods of Assessment, Search and Rescue (ASR) of INSARAG (NATO) [3] have been increased its efficiency. Introduction: Several studies have shown a lack of effective communication skills amongst medical students, particularly concerning how to deliver bad news. Currently, discussions with undergraduated students about communication, including 'SPIKES' protocol are necessary but the act of transmitting bad news must be present. The aim of this study is to investigate the perspective of students related to this subject. Methods: Anonymous online surveys were applied to 70 fifth-year medical students, containing quantitative and qualitative questions, on the 'SPIKES' protocol and describing their perception of training for difficult news communication techniques during academic training. Results: A total of 70 students completed the assessments, mean age 26.4 and 68.1% (n = 48) female. They were asked if they had practical training on the subject until their respective current periods and 77.1% (n = 54), denied having had any kind of practice, 84.3% said being not prepared to give difficult news to patients and family members, although the vast majority of participants demonstrated empathy during communication processes. At last we found that only a little more than half of the students had theoretical contact with protocols and preparation to give difficult news, and that most did not receive any practical training for such a scenario. The medical students could gain competencies in breaking bad news using a practical approach, valued theoretical and practical ones. The implementation in teaching of these skills in medical schools is essential for greater safety of the professional in their daily practice and for the best care of patients and their relatives. Table 1 . Conclusions: MDW can be considered as useful tool in predicting severity of COVID-19 disease and patient's outcome. *For scientific discussion only, the measurement of MDW on the Uni-Cel DxH 900 analyzer is intended for use with adult patients presenting to the emergency department, on whom a white cell differential test has been ordered, as an aid in the early detection of patients with or developing sepsis. The causes for MET activation were mostly C-problems (5,760 (41%)), followed by D-problems (4,076 (29%). A B-problem caused a MET-activation in 26% (n = 3,649) and an A-problem in 11% (n = 1,589). The MET arrived after 4 ± 3 min with a time of care of 24 ± 23 min. Table 1 shows selected invasive and therapeutic measures by MET. 201 (11%) had a difficult airway (> 1 intubation attempt and/or change of procedure) with a need for coniotomy in 8 of these patients (4%). In-hospital emergency care is demanding and requires advanced competencies in invasive hemodynamic and airway interventions of the attending physicians. Taking these special features into account, there is a need for specific recommendations regarding training and equipment of MET, that need to consider the resources and the patient population of the respective hospitals. Intubation 1757 (12) Introduction: Prehospital care of severe traumatic brain injury (TBI) focuses on preventing the secondary insult caused by hypoxemia and hypotension. Current guidelines advocate early endotracheal intubation (ETI) in patients with suspected severe TBI. Although potentially beneficial, prehospital ETI is associated with a high rate of complications. The ability to accurately diagnose TBI in the field is limited. We investigated the prevalence of clinically significant TBI among patients intubated in the field due to presumed severe TBI. Methods: Data were retrospectively collected from EMS and hospital records of trauma patients for whom ETI was attempted on the scene (either successfully or not) and who were transferred to Rambam Health Care Campus, Israel between 2014 and 2020. The indication for ETI was extracted. The primary outcome was clinically significant head trauma (a significant lesion on head CT, need for neurosurgery, or abnormal neurologic examination after extubation) among patients intubated due to suspected severe TBI. We excluded patients intubated due to non-traumatic conditions, burns, during CPR, facial trauma compromising airway, hypoxemia, and severe shock. Results: A total of 349 patients were included in the final analysis (Fig. 1 ) -95.7% suffered blunt trauma, 82.8% were male, and the median age was 34 years (IQR 23-57). A total of 253 patients (72.5%) had clinically significant head trauma. In a multivariable analysis, risk factors for significant head injury were GCS < 9 (OR 3.58, 95% CI 1.96-7.69, p < 0.001) and alcohol intoxication (OR 0.16, 95% CI 0.06-0.46, p < 0.001). Conclusions: A substantial portion of patients intubated in the field due to suspected severe TBI, did not suffer a clinically significant head injury. This population may be exposed to the risks and complications of prehospital ETI without any potential benefits. Patients with a higher field GCS and those suffering from intoxication have a higher risk of misdiagnosis and potentially unnecessary ETI. Introduction: Decompressive craniectomy (DC) has demonstrated to be effective for intracranial pressure (ICP) control, although not relevant results have been observed concerning mortality reduction in TBI. One hypothesis for this outcome is that DC does not return intracranial compliance (ICC) for its previous state, before acute injury. The present study aimed to assess the morphological alterations in intracranial pressure pulse waveform (ICPPW) among neurocritical care patients with and without DC, by comparing the variations of ICPPW according to elevations in ICP by two techniques. Methods: Patients requiring ICP monitoring because of severe traumatic or spontaneous conditions were included. ICP mean values were compared with ICPPW features (P2/P1 ratio, time-to-peak [TTP]) obtained from ICP invasive catheters and a new technology that captures beat-by-beat skull pulsations (B4C). Elevation of ICP was produced by means of ultrasound-guided internal jugular veins compression. Analysis of ICPPW features were compared between techniques and distributed for three groups: intact skull (exclusive burr hole for ICP monitoring), craniotomy/large fractures (group 2) or DC (group 3). Results: 57 patients were analyzed, 32 with both techniques. 21 (36%) presented no skull defects, whereas 15 (26%) had DC. ICP was not significantly different between groups (p = 0.56). Significant elevation was observed for P2/P1 ratio for groups 1 and 2, whereas reduction was observed in group 3 (elevation of ± 0.09 for groups 1 and 2, whereas reduction of 0.03 for group 3, p = 0.01). B4C disclosed strong correlation with invasive ICPPW features (AUC 0.86 for P2/P1 ratio, 0.81 for TTP). Conclusions: Intracranial compliance was significantly more impaired among decompressive craniectomy patients, although this technique seems to be protective for further influences of ICP elevations over the brain. Correlation between techniques was significant, indicating the B4C system as promising to monitor intracranial compliance noninvasively. Introduction: The mechanism of acute brain injury initiates cascades of consequences which are significant factors of poor neurological outcome [1] [2] [3] [4] [5] [6] . Methods: The analysis was performed in patients with severe isolated TBI. Bronchoalveolar lavage fluid was collected at admission, for third and seventh day after incident. Activation of intrinistic, extrinistic and endoplasmic reticulum pathways were measured. Results: Results showed significantly increased levels of selected apoptotic factors concentration after 72 h and on the 7thday after incident. We found a significant correlation between apoptotic factors, GCS and 28-day mortality. There were no statistically significant correlations between apoptosis and EVLWI and PVPI. Conclusions: Activation and imbalance of apoptotic pathways seems to be an important process in lungs after severe brain trauma. Activation of apoptosis correlates with the severity of brain injury. Introduction: Heterogeneity represents a major barrier in efforts to find effective treatments for patients with moderate and severe traumatic brain injury (TBI). One approach to address heterogeneity might be to resolve undifferentiated populations into subphenotypes which would have greater intrinsic biological uniformity. We hypothesized that clinically meaningful subphenotypes can be identified using unsupervised computational approaches applied to electronic health records and physiological time series (PTS) data. Methods: Adult patients admitted to the ICU for management of TBI were selected from a multi-center database (eICU), and clinical, laboratory and physiological time series data were extracted. Unsupervised clustering algorithms were implemented accounting for mixed data types. Clusters were characterized according to outcome distributions at discharge, and differences in physiology. The clustering algorithm was validated externally on an analogous TBI population in an independent, single-center dataset (MIMIC-III). Results: Among 4,450 patients admitted to intensive care with TBI, we identified four clusters (a, b, c, d) each with a distinct outcome probability distribution, and each associated with unique, clinically relevant pattern of laboratory/PTS signatures. Subphenotype (a) captured TBI patients who had the highest likelihood of survival and favorable neurological outcome, while patients in subphenotype (d) had the highest risk of death and unfavorable neurological outcome. Results were reproduced in the MIMIC III cohort when eICU clusters were assigned using a multi-class classification (Fig. 1) . Conclusions: Using unsupervised machine learning, we identified four distinct and clinically meaningful clusters in a large sample of TBI patents admitted to the ICU. Patients assigned to specific clusters had distinct outcome probabilities and unique data signatures suggesting that they are plausible candidate subphenotypes. Introduction: Traumatic brain injury (TBI) is a global health problem which constitutes a leading neurological cause of death and also results in life-long disability in many survivors. The aim of this study was to identify data signatures in TBI patients recorded in the first 24 h of ICU admission. We tested the hypothesis that these signatures are associated with short term clinical outcomes. Methods: A total of 4,450 patients admitted to the ICU for management of TBI were selected from the multisite clinical database (eICU) and clinical, laboratory and physiological time series data were extracted. Outcomes were mortality and neurological outcome at discharge. The eICU developed machine learning algorithms were externally validated on an analogous TBI sample in an independent single-center ICU database (MIMIC-III). Model performance metrics were compared with Reference International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) and Corticoid Randomization After Significant Head injury (CRASH) logistic regression models. Results: The computational models performed well for both neurological outcome prediction and mortality prediction, with test metrics that compared favorably with Reference IMPACT and CRASH scores (Fig. 1) . External validation utilizing MIMIC III corroborated the results from eICU for both neurological outcome and mortality suggesting robust generalizability. Top predictive features included age, PTS derived variables, glucose, platelet count, white blood cell count, and Glasgow Coma subscores, all originating from the first 24 h of ICU admission. Conclusions: Results indicate that computational models trained with data available in the first 24 h after admission are predictive of shortterm neurological outcome and mortality in ICU-stratum TBI patients. Timely characterization of severity and clinical trajectories could open a window for targeted interventions to ameliorate outcomes in patients with moderate and severe TBI. Introduction: In ICU, raised ICP is a frequently encountered problem for which different management strategies can be adopted [1] . Intensity of these interventions can be quantified using the TIL scale, a reliable measurement with a high degree of validity for assessing ICP management in patients with traumatic brain injury (TBI) [2] . Studies showed significant center variation in TIL treatments for patients with TBI, possibly reflecting aggressive use or inappropriate escalation strategies [3] . Methods: We developed a user-friendly TIL scale calculator to improve ICP management. Based on the intuitively started ICP management, current ICP and desired target ICP, a TIL-coefficient will be calculated, which will numerically and visually reflect whether past and current treatment is appropriate, inadequate or overly aggressive. Additionally, a TIL scale-based algorithm can optimize ICP management. Hereby, inappropriate escalation or de-escalation could be avoided. The indication, relevance and ease of use of the TIL scale calculator was peer reviewed in three Belgian hospitals. Results: The TIL scale calculator, with both TIL-coefficient and TIL scale algorithm, resulted in more awareness regarding ICP management. The numerical and visual feedback of past and current ICP management and possible treatment modalities was an advantageous tool, leading to more evidence-based decision making. However, suggestions from the TIL scale based algorithm should always be critically assessed prior to implementation in daily clinical practice. Conclusions: This user-friendly TIL scale calculator is based on the TIL scale, which has been proven to be reliable and valid. Implementing this tool in daily clinical practice can lead to more specific and targeted ICP management. To assess reliability and validity of ICP management based on the TIL scale calculator, further studies are warranted. Introduction: The 1A receptor HTR1A is one of the most abundant serotonin receptors in the brain and immune cells that contribute to stress, anxiety, aggression, cognition, and immune responses [1, 2] . Single nucleotide polymorphism (SNP) HTR1A C(-1019)G (rs6295) site is located in promoter area and affects HTR1A gene transcription [1] . Allele G associates with depression, post-traumatic mental disorders, and resistance to antipsychotic drugs [1] . Altered expression of the HTR1A gene associates with increased oxidation due to a deficient anti-oxidation mechanism [3] . Our study aimed to investigate whether the HTR1A SNP links to neurological impairment and circulating oxidized DNA (oxDNA) in patients re-admitted to a neuro ICU. Methods: Study cohort included 240 neuro ICU patients (median age 54 years, range 18-88 years) with consequences of trauma, anoxic brain injury, stroke, brain tumor. HTR1A rs6295 polymorphism was studied using an HTR1A specific oligonucleotide tetra primer set, PCR, and gel electrophoresis. Oxidized DNA (oxDNA) concentration in plasma was determined with antibodies to 8-oxo-2'-deoxyguanosine and membrane immunoassay. Results: On day 1, NIHSS scores (but not Glasgow or SOFA scales) revealed differences between patients with CC genotype vs. G carriers: medians 8 (6.5;12.5) vs. 13 (9.2;18.0), respectively (p = 0.012, Mann-Whitney) (Fig. 1) . Increased oxDNA values were associated with CC genotypes: odds ratio (OR) 2.213, 95%CI%: 1.201-4.077, p = 0.016 (Fisher test), n = 240. This association was significant only in a cohort of patients with no pneumonia (OR 2.991, 95%CI%: 1.170-7.645, p = 0.036, n = 92). The results link enhanced neurologic impairment and decreased oxDNA in circulation in the cohort of carriers of HTR1A G resistant to a lung infection that may stem from the dual effect of the mutant gene in neural and immune cells. Introduction: A comprehensive study of 23 patients with chronic disoders of consciousness (unresponsive wakefulness syndrome, minimally conscious state), treated in the ICU department of Russian Polenov Neurosurgical Institute, was conducted in order to clarify the mechanisms of impaired functions and the possibility of regeneration of striated muscles in patients with severe damage of the central nervous system. Methods: All patients underwent PET-CT with 18F-fluorodeoxyglucose (18F-FDG) brain, skeletal muscles of the shoulder girdle, to identify the asymmetry of muscle metabolism comparison with the scale of muscle tone. 18F-FDG was administered intravenously in a dose125-250 MBq. For pathomorphological examination, muscles tissue was taken by surgeon under local anesthesia with a 1% solution of novocaine, the size of the muscle biopsies was 1 × 1 cm histological examination included fixation of the biopsies in buffered 10% neutral formalin, conducting alcohol wiring and filling in paraffin.Immunohistochemical (IHC) reactions were performed on paraffin sections according to the standard protocol, with the antigen unmasking in a water bath. Primary antibodies were used: dystrophin (ab85302), beclin-1 (ab62557), myosin (Fast, DBS), desmin (DBS). Structural changes in skeletal muscles in DOC patients with CIP have a progressive nonspecific degenerative-atrophic character with more pronounced manifestations on the side of paresis. Intracellular and metabolic changes indicate that, despite the deepseated process, changes are usually reversible and the regenerative potential of muscle fibers is preserved. Analysis of 18F-FDG metabolism of the shoulder girdle muscles in patients with CHF showed its decrease regardless of the side of paresis. Conclusions: A clear correlation of the metabolism level and changes in muscle tone, deep reflexes was not found, but a certain priority was found in the skeletal muscles innervated by the dominant hemisphere. Acknowledgement: Supported by RFBR grant 19-29-01,066. The lack of precise monitoring in these patients plays a major role in the delayed identification of DCI. The main objective of this study is to analyze heart rate variability (HRV) data from SAH patients for further analysis, using machine-learning to aid us in identifying imminent DCI. We hypothesize that machine learning, may detect incipient DCI using HRV trends. Methods: HRV data from a previous study underwent comprehensive analysis. The HRV material was collected prospectively from a cohort of 64 patients with aSAH admitted to the neurointensive care unit at Sahlgrenska University Hospital, Gothenburg, Sweden, 2015-2016. HRV data was cleaned from noise, quantified and labelled in multiple steps and analyzed using the Random Forest supervised machine learning algorithm. Results: HRV data was obtained in 55 patients. After excluding 19 patients due to low quality data, a total of 36 patients remained, 12 of which developed DCI. The machine learning algorithm was able to identify 71% of patients with DCI. Nevertheless, DCI was also detected in non-DCI patients, demonstrating a specificity of 57% Conclusions: This study implies that processing of HRV, using machine learning can be helpful in patients susceptible to DCI. The results display an adequate sensitivity; however, the specificity was low. Our data support further investigation, correlating HRV and cerebral ischemia. More studies are needed to further evolve a secure method to detect cerebral ischemia using dynamic HRV values. a machine learning (ML) algorithm can detect events with cerebral hypoperfusion and ischemia in patients in the ICU or OR. Methods: In a first of a three-phase observational study with the aim of training a ML-algorithm to predict and detect cerebral ischemia using data collected from bedside monitors, we studied patients undergoing carotid endarterectomy. Patients were monitored with SpO 2 , continuous ABP, ECG, near-infrared spectrometry (NIRS), and electroencephalography. Data was exported to a computer, cleaned, and labelled. The perioperative period was divided into 7 events. Feature extraction of the data was done in Python programming environment. Heart rate variability parameters were extracted from the ECG. We quantified all variables per minute. This provided us with a large matrix of all features for each minute (data point). The data points were then labelled with the event name. The feature matrix was used to train a random forest algorithm. Results: Nine patients were included in a pilot study. Recognition of the clinical events was achieved with an accuracy of 82-98%, precision (specificity) 86-98%, and recall (sensitivity) 87-98%. Accuracy was not affected when NIRS-values were excluded from analysis. Using decision tree or support vector machine algorithms yielded similar results. Conclusions: It is possible for a ML-algorithm to differ between clinical events, including clamping of the carotid arteries, in a controlled environment. Artificial intelligence and ML can help utilize big data generated in the ICU and OR. We will continue our research to help develop models able to aid clinicians detect cerebral ischemia in real time, using data generated from bedside monitors. Introduction: Cardiac complications are frequently seen in patients with subarachnoid hemorrhage (SAH). Previous studies that examined the relation between electrocardiographic and echocardiographic (echo) changes in SAH patients and patient outcomes were conflicting [1, 2] . Methods: In this single-center retrospective cohort study, data was collected from ICU patients with an aneurysmal SAH between 01/06/2017 and 31/12/2020. We reviewed electrocardiogram (ECG) on admission and defined an abnormal ECG as either a significant ST-elevation or depression, a significant T-wave inversion or an abnormal QTc (> 440 ms for men, > 460 ms for women). We collected echo findings (left ventricular ejection fraction, EF) when available. Univariate regression analysis or Chi-square testing was used wherever applicable. Results: A total of 150 SAH patients were identified (patient characteristics in Table 1 ). 74 patients had a normal ECG (group 1), in 71 patients ECG changes were found (group 2), 5 patients had no ECG on admission and were excluded. A prolonged QTc was found in 66%, ST-T changes in 12%, both in 21%. A total of 7 patients received an echo in group 1 (9%) compared to 18 in group 2 (25%). Overall, 10 echoes showed reduced EF (0% in group 1 vs 55% in group 2). Mean ICU length of stay (LOS) was lower in group 1 compared to group 2 (7.7 days vs 12.2 days resp, p = 0.003). Hospital mortality was lower in group 1 (6.7% vs 20.0%, p = 0.021). Reduced EF was not associated with higher mortality. Conclusions: ECG changes in SAH patients are associated with longer ICU LOS and higher hospital mortality. Echocardiography was performed only in 25% of patients with ECG changes. Since more than 50% of echoes in patients with SAH having an abnormal ECG showed reduced left ventricular function, an abnormal ECG on admission in patients with SAH should trigger to perform an echocardiography to detect cardiac complications. Introduction: The aim of the study was to evaluate the effect of lithium chloride in various dosages on mortality in ischemic stroke in rats. The study used male rats weighing 312 ± 12.5 g. The model of Long's focal ischemia was used as a basis. The animals were split into 5 groups: false-operated, control (model of ischemic stroke with the introduction of 0.9% NaCl) and three groups in which the simulation of ischemic stroke was combined with the introduction of lithium chloride in various concentrations (4.2 mg/kg, 21 mg/kg and 63 mg/ kg, respectively). The drug was administered daily for 14 days. Daily, cumulative, and final mortality rates were evaluated. Results: According to the results of the experiment, the following data on mortality were obtained: false -operated rats -0 out of 8, control group -13 out of 22 (lethality 59%), group III (LiCl 4.2 mg/kg) -8 out of 14 (lethality 57%), p > 0.05 relative to the control, group IV (LiCl 21 mg/kg) -6 out of 15 (lethality 40%) p > 0.05 relative to the control and in group V (LiCl 63 mg/kg), 4 out of 15 animals died (lethality 27%) p = 0.0317 relative to the control. The highest mortality rate in the control group was observed on day 1 (22.7%). In groups IV and V, the daily mortality rate was evenly distributed, in group III the largest number of animals died on day 3 (3 out of 14; 21.42%). The cumulative mortality rate in group III significantly differed from the control one only on day 2 (p < 0.05). In group IV, cumulative mortality was significantly lower up to 7 days (p < 0.05). In group V, cumulative mortality was significantly lower (p < 0.05) until 14 days after euthanasia. Methods: The study used male rats weighing 315 ± 13.5 g. The long focal ischemia model was used. The animals were split into five groups: false-operated (median incision in the projection of the carotid artery without ischemia), control (model of ischemic stroke with the introduction of 0.9% NaCl) and three groups with the introduction of lithium chloride at concentrations of 4.2 mg/kg, 21 mg/kg and 63 mg/kg, respectively. Lithium chloride was administered immediately after the termination of the occlusion of the middle cerebral artery and then every 24 h until euthanasia. To assess the degree of brain damage, the animals underwent magnetic resonance imaging (MRI) on day 2, and brain sections stained with 2,3,5-triphenyltetrazolium chloride were evaluated on day 7 after euthanasia. Results: According to MRI data, lithium chloride at a dose of 4.2 mg/ kg did not significantly affect the volume of ischemic stroke and perifocal edema in relation to the control group on day 2 (p = 0.9). When using a dose of 21 mg/kg, the volume of stroke (p = 0.04) and perifocal edema was significantly lower (p = 0.03) than in the control group (by 25% and 18%, respectively). Lithium chloride at a dose of 63 mg/kg significantly reduced the volume of stroke (45%, p = 0.004) and perifocal edema (35%, p = 0.007). When determining the volume of the lesion on day 7, the data were comparable with the results obtained on day 2. When using a dose of 21 mg/kg, the stroke volume was 20% lower (p = 0.04) than in the control group. Lithium chloride at a dose of 63 mg/kg reduced stroke volume by 40% (p = 0.0037). Conclusions: Lithium chloride at dosages of 21 mg/kg and 63 mg/ kg significantly reduced the volume of ischemic stroke and perifocal edema of the brain, but when using a concentration of 63 mg/kg, the effect was more pronounced. Introduction: Worldwide, ischemic stroke is a major cause of death and morbidity. Important target times to improve patient outcome are door-to-CT time, door-to-needle time (DNT) and door-to-groin time (DGT). Since 2017 stroke data was prospectively collected in the framework of stroke center accreditation in ZOL Genk, Belgium. We hypothesized that this would improve target times and enlarge the proportion of treated patients. Methods: All patients admitted for stroke or TIA at ZOL stroke center, Genk, Belgium, between 2017 and 2020 were included. Quality indicators were proportion of treated patients, door-to-CT time, DNT and DGT. A structured data collection and a stroke working flow template were created to enhance and harmonize stroke diagnostics and treatment in 2019. As of 2020, intravenous thrombolysis was administered immediately at the CT scan. Results: In total 1255 patients were included. The number of patients registered with stroke and TIA increased by 80% over 4 years (p < 0.0001). Median age differed over time: 78 years in 2017 vs. 74 years in 2020 (p = 0.03). NIHSS at admission decreased over the last two years (p < 0.0001). In addition, onset-to-door time, door-to-CT time and DNT were different (p < 0.0001, p = 0.0005, p < 0.0001). DGT was similar between consecutive years (p = 0.54). The proportion of conservatively treated patients increased over time by 15% (p = 0.0001) ( Table 1) . Conclusions: Patients were younger and presented with milder strokes in comparison with earlier years. Increased detection of stroke patients was probably due to underreporting of milder strokes in the past. The higher proportion of conservatively treated patients hereby may have affected target times such as a prolonged door-to-CT time. The sudden drop of DNT in 2020 can be explained by administration of thrombolysis already at the CT scan. Increased awareness and training among staff probably led to increased diagnoses of acute cerebrovascular accidents in our stroke center and may help to further reduce target times. NIHSS score at admission and mechanical ventilation were independent predictors of poor functional outcome. Adjusting on decision to withhold LST did not modify these associations. Our study showed that survival and functional outcomes remain poor in stroke patients admitted in ICU. Both neurological severity and organ support therapy were independent predictors of poor outcomes. Introduction: Cerebral vasospasm is the classic cause of neurological deterioration after aneurysmal subarachnoid hemorrhage (SAH) and contributes to morbidity and mortality. Predicting the onset of cerebral vasospasm remains a challenge. Recent research suggests an association between vasospasm and arterial hypertension, thus rendering changes in blood pressure (BP) a candidate for predicting increased risk of cerebral vasospasm. We investigated for a correlation between arterial hypertension following SAH and the onset of symptomatic cerebral vasospasm. Methods: This was a retrospective cohort study of coiled aneurysmal SAH patients between January 2017 and June 2020 in Cork University Hospital. Post-coiling 4-hourly BP readings were collected up to day 9 or discharge. Symptomatic cerebral vasospasm was defined as a focal neurologic deficit or decrease of > 1 point on the Glasgow Coma Scale lasting > 1 h, non-attributable to other causes. Logistic regression analysis was performed for all the BP readings with adjustment for age, sex, presence of hydrocephalus and history of hypertension. Results: A total of 56 patients were included in the analysis, 21 developed vasospasm (37.5%). Mean day of vasospasm onset was day 6 (± 2) post-coiling. A 10 mmHg increase in systolic BP was associated with an increased risk of cerebral vasospasm [Odds Ratio (OR) = 1.63; 95% confidence interval (CI) 1.04-2.6; p value < 0.05] (Fig. 1) . The association was stronger in patients with pre-existing hypertension [OR = 2.29; 95% CI 1.1-4.77; p value < 0.05]. Cubic spline analysis showed a positive linear relationship between systolic BP and predicting the risk of vasospasm. No significance was found in diastolic or mean arterial pressure. Conclusions: An increase in systolic BP post-coiling for SAH correlated with increased risk for cerebral vasospasm. Systolic BP may be of use in anticipating patients at increased risk for vasospasm, thereby prompting closer monitoring and earlier therapeutic intervention. Introduction: Several phenyl-containing acids which are metabolites of tyrosine and phenylalanine have been found in the cerebrospinal fluid (CSF) of neurosurgical patients with various intracranial diseases or injuries [1] . The goal of this study was to determine if the content of one of these acids (4-hydroxyphenyllactic acid, p-HPhLA) was specific for the neurosurgical patients with the suspected bacterial meningitis. The residues of CSF samples from neurosurgical patients (n = 84) were obtained after diagnostic lumbar puncture, including patients with the suspected bacterial meningitis (n = 9). Concentration of p-HPhLA was measured by gas chromatography-mass spectrometry [1] . In a prospective cohort study analyzing retrospectively 297 consecutive non-traumatic SAH patients admitted to the ICU in a tertiary academic medical center, we aimed to identify factors associated with prolonged MV and to create a predictive score for prolonged MV. Methods: Using multivariable generalized linear models, we identified factors associated with MV > 48 h, > 7 days, and > 14 days. Patients who were mechanically ventilated but died before 48 h, 7 days or 14 days and those never ventilated were excluded from the analysis. We incorporated those factors into a new prognostic score (the RAISE score: pRolonged ventilAtion In Subarachnoid hEmorrhage patients) to predict prolonged MV > 7 days. The score was developed by arbitrarily choosing 60% SAH patients in a training dataset which was further internally validated. Results: The median age of patients was 57 (IQR 47-68) years and median admission Hunt&Hess grade (H&H) was 3 (IQR 1-5). The median duration of MV was 9 (IQR 2-20) days in 242 (82%) patients who required MV. Associations were found between a higher Acute Physiology Score (APS) and MV > 48 h, > 7 days and > 14 days, as well as between a higher H&H and MV > 7 days and > 14 days. Early neuroimaging findings (hydrocephalus; high-grade SEBES, Subarachnoid Hemorrhage Early Brain Edema Score) were associated with MV > 48 h. High-grade SEBES and co-occurrence of intraparenchymal bleeding were associated with MV > 7 days. Neuroimaging was, however, not associated with MV > 14 days. The RAISE score included age, APS, H&H, SEBES, and the presence of ICH stratifying the risk of MV > 7 days (See Fig. 1) . Conclusions: Disease severity and neuroimaging findings detected within 24 h of ICU admission are associated with the need for prolonged MV in patients with SAH. These results may be helpful to better anticipate the course of therapy. Introduction: Optimal fluid management in patients after subarachnoid hemorrhage (SAH) aims at optimization of cerebral flood flow and brain oxygenation. Here, we investigated the effects of fluid management on brain oxygenation by integrating advanced hemodynamic monitoring (PiCCO) and invasive neuromonitoring. Methods: This observational cohort bi-center study included data of consecutive poor-grade SAH patients, who underwent PiCCO monitoring and invasive neuromonitoring. Fluid management was guided by the transpulmonary thermodilution system and aimed at euvolemia (cardiac index, CI ≥ 3.0 l/min/m 2 ; global end-diastolic index, GEDI 680-800 ml/m 2 ; stroke volume variation, SVV < 10%). Patients were managed using a PbtO 2 targeted protocol to prevent brain tissue hypoxia (BTH, PbtO 2 < 20 mmHg). To assess the association between CI and PbtO 2 and the effect of fluid challenges on CI and PbtO 2 we used generalized estimating equations. Conclusions: In this study, a moderate association between increased cardiac output and brain oxygenation was observed. Fluid challenges may improve PbtO 2 only in the presence of BTH at baseline. Individualized hemodynamic management requires advanced cardiac and brain monitoring in critically ill SAH patients. COVID-19-induced neuroinflammation may account for this: innate immune cells of the brain become activated, due to systemic inflammation and a compromised blood-brain barrier, causing a neuroinflammatory state of the brain resulting in neuronal damage. Methods: This prospective single center observational study serially assessed plasma inflammation and brain damage markers during hospital admission in both ICU and ward patients. Samples were collected every 5-7 days during hospital stay and analyzed using Simoa Neurology 4-plex for neuronal/neuroinflammatory biomarkers and Luminex Milliplex assay for cytokine determination. After six to eight months, included patients were asked to join additional cognitive examination, consisting of the There is a probability of using D-dimer in CVT risk scoring and pre-imaging negotiation, and for that purpose, larger and higher-quality studies are needed. Introduction: Disoders of consciousness (DOC) patients often show severe sleep fragmentation, which is likely caused by structural changes in the brain areas responsible for sleep maintenance. The study was based on the results of examination and treatment of 43 DOC patients. The average duration of DOC -4.4 ± 0.7 months. The 1 group -patients with a total score CRS-R of 0-5 points, 2 group of 5-8, and 3 group -> 9. All patients underwent polysomnography (PSG) for 2 days, melatonin level was measured 6 times a day: at 8 am, 15 pm, 18 pm, 21 pm, 24 pm and 3 am, daily urine collection to determine 6-sulfatoxymelatonin in the daily and night portions of urine. MRI (3 Tesla) with a detailed assessment of structural changes in the brainstem, hypothalamus and thalamus according to the "MRI atlas of the human hypothalamus" by M. Baroncini. Also, PSG data were compared with PET CT of the brain. Results: 41.7% of patients of group 1, there were no sleep cycles. The NREM/REM ratio in patients of the 1 group was almost twice as high as in patients of the 2 and 3 groups. In patients of 3 group total sleep time was higher, and sleep cycles were recorded in 58.3% of patients, the average value of the N2/total sleep time ratio was higher, but the average value of the N1/total sleep time ratio in patients of the third group was lower than in other groups. Melatonin level was maintained in patients of all groups. Relationship of PSG changes in the FDG PET data was not found. When analyzing macroscopic changes of the structure morphology (thalamus, hypothalamus, midbrain, corpus callosum), relationship with the assignment to the group and the PSG data was not identified. There are no clearly defined PSG patterns that reliably define each of the reviewed DOC states. We have received evidence indicating that sleep in DOC is under normal homeostatic controllevel and rhythm of melatonin secretion were preserved in all groups. Acknowledgement: Study was supported by RFBR grant 19-29-01-066. Introduction: Patients with acute brain injury (ABI) commonly receive mechanical ventilation (MV) which can be harmful due to lung injury and adverse physiological effects on the brain. Our aim was to explore relationships between MV and outcome of patients with ABI. We hypothesize that MV variables are important determinants of shortterm ABI outcomes. Methods: Adult patients with traumatic brain injury (TBI) or stroke who received MV as part of their care in the ICU were selected from large multicenter database (eICU). A set of features was crafted based on current recommendations for lung-protective MV and included time "out-of-range" (OOR) for: tidal volume per ideal body weight (> 8 ml/kg), plateau pressure (> 30 cmH 2 O), PEEP (< 5 cmH 2 O). Outcomes were defined as "Unfavorable" for patients who died or whose discharge motor Glasgow Coma Score (mGCS) was < 5, and "Favorable" for patients who were alive and had a mGCS ≥ 5 at discharge. Two models were created: (1) A clinical model which uses only the first value recorded for each feature; and (2) A combined model which included predefined OOR MV variables. Results: Data were analyzed on 839 and 1,221 ICU stays for TBI and stroke, respectively. Clinical and combined models had an AUROC of 0.67 ± 0.07 and 0.79 ± 0.13 for Stroke and an AUROC of 0.70 ± 0.07 and 0.81 ± 0.07 respectively for TBI. A number of OOR MV variables and respiratory physiologic variables were found to be significant (Fig. 1) . Longer durations of exposure to OOR tidal volume, PEEP and plateau pressure were identified as top contributors with longer OOR durations predictive of unfavorable outcome. These results indicate that exposure to non-lung protective MV may contribute to clinical and neurological outcomes in stroke and TBI patients. They support the need for clinical trials evaluating optimal MV strategies in this population. Introduction: Blood sampling is a recognized and modifiable contributor to iatrogenic anemia in pediatric critical care units (PICU). Methods: We aimed to bundle and evaluate current evidence of interventions to lower the incidence of iatrogenic anemia and transfusion by lowering diagnostic blood loss in hospitalized patients. We performed a systematic search in PubMed, Ovid MEDLINE, All EBM Reviews (Cochrane) and Embase until May 2021. Trial eligibility, data extraction and Risk of Bias (ROB Cochrane Collaboration tool) assessment were independently done by 2 or 3 reviewers. Results: Thirty-nine trials were retained after screening 16,132 papers. ROB was high in all studies, but one. Many studies evaluated multiple interventions, of which most done in adults. All 7 adult studies evaluating small blood tubes observed a significant reduction in blood loss, only 1 observed a positive effect on hemoglobin (Hb) / transfusion. 8 adult studies evaluated closed blood sampling: all showed a significant reduction in blood discarded with varying effects on Hb. 1 neonatal study showed that returning blood discarded was effective in lowering transfusion volume. Point-of-care testing was found effective in reducing transfusion in 1 adult study; 5 neonatal studies reported divergent effects. Another study showed adults being significantly sampled more with arterial line vs. without. The remaining 16 trials that implemented bundled interventions showed mixed results: only 3/10 adult studies observed a significant lower transfusion rate, the 6 pediatric trials observed a lower transfusion rate when bundles included education/protocols. Conclusions: Current evidence on interventions to reduce diagnostic blood volume and associated complications is highly heterogeneous. Using smaller tubes and closed-loop sampling may be effective in adults, while bundled interventions with protocols/teaching seem promising in the pediatric population. population PK model was constructed with NONMEM v7.4.1. Monte Carlo simulations (10,000 patients) provided individual anti-Xa versus time curves to allow evaluation of the accuracy of sample timing with Bayesian analysis. Accuracy was described by the relative mean prediction error (rMPE) for bias (< 15%) and relative root mean squared error (rRMSE) for imprecision (< 25%). Results: Anti-Xa levels versus time profiles were adequately described using a 2-compartment model with following covariates associated to clearance (CL): CRP, D-dimer, CKD-EPI-eGFR, corticosteroid and vasopressor use. Target level (0.3 IU -0.7 IU/ml) achievement was most optimal for b.i.d. 5700 IU (Fig. 1) Introduction: OctaplasLG ® is a solvent/detergent-treated, coagulation active plasma product for treating complex coagulation factor deficiencies, such as coagulopathy due to severe hepatic failure or massive transfusion, and as a substitution therapy in coagulation factor deficiencies in situations where specific factor concentrates are not available, or in emergency situations where precise laboratory diagnosis is not possible. OctaplasLG ® is supplied frozen; the thawed product is stable during refrigerated storage for up to 5 days. Recently, a new freeze-dried form was developed (OctaplasLG ® Lyo) to further increase ease of logistics and utilization. Methods: Three OctaplasLG ® Lyo batches for process performance qualification were manufactured at Octapharma AB, freeze-dried and reconstituted with sterilized water. Twelve batches of frozen Octapla-sLG ® were used for comparison; batches were assessed directly after thawing, as well as after storage of the thawed product at 2-8 °C for ≤ 6 days. All batches were assessed for global coagulation parameters, important coagulation factors and protease inhibitors, and activation markers of coagulation and fibrinolysis. Results: Frozen OctaplasLG ® and freeze-dried OctaplasLG ® Lyo demonstrate identical quality profiles upon thawing and reconstitution, respectively; all parameters were in line with levels mandated by the European Pharmacopoeia. In addition, OctaplasLG ® Lyo exhibited comparable/higher quality for temperature-sensitive parameters, such as levels of factor V, factor VIII, and protein S, compared to thawed OctaplasLG ® after 6 days refrigerated storage (Fig. 1) . Conclusions: OctaplasLG ® frozen and freeze-dried products have equally high biochemical quality. The key features of the new freezedried version (OctaplasLG ® Lyo) are the fast reconstitution time and flexibility of storage conditions (refrigerated/room temperature), which has advantages in emergency situations and in ex-hospital settings. factor replacement with fibrinogen concentrate (FC) and prothrombin complex concentrate (PCC) may be superior to current standard of care with ratio-based plasma resuscitation via a massive hemorrhage protocol (MHP). FiiRST-2 is investigating whether FC + PCC given ≤ 1 h after hospital arrival is superior to standard of care. Methods: FiiRST-2 is a randomized, parallel-control, superiority trial with an adaptive two-stage design, performed in eight Canadian Level One Trauma Centers. Bleeding trauma patients > 16 years old (N = 350) receive FC + PCC or a minimum 2:1 red blood cells (RBCs):plasma transfusion plus platelets, until the second MHP pack has been given, MHP is terminated, or 24 h has elapsed from admission (Fig. 1) . Exclusion criteria include receipt of > 2 units RBCs before randomization, > 3 h elapsed from injury, catastrophic brain injury, or known congenital or acquired bleeding disorders. The primary endpoint is superiority in the number of composite allogeneic blood product units transfused ≤ 24 h after admission. Secondary endpoints include RBC units transfused ≤ 24 h after admission, ventilator-free days, and 28 day mortality. Adverse and serious adverse events, including thromboembolic complications, will be assessed through 28 days. Results: FiiRST-2 has enrolled 3 patients at 1 site and is expected to complete in Q1 2023. This study could have a major impact on clinical practice and improve the management and outcomes of bleeding trauma patients. FiiRST-2 will determine if early use of factor concentrates (FC + PCC) is superior to standard of care (ratio-based plasma resuscitation) in these high-risk patients. We studied the mesoporous carbon sorbent VNIITU-2, modified with 3-phenylpropanoic acid (PhPA), because this metabolite of normal gut microbiota has a number of positive properties. Previously, we showed that PhPA is always present in blood of healthy humans, but is absent in patients with sepsis. The aim of the work is to evaluate the ability of the modified sorbent to perform targeted sorption of metabolites associated with sepsis and desorption of the modifier. In an experiment in vitro, created model solutions in blood plasma with sepsis-associated metabolites such as 3-phenyllactic (PhLA), 2-(4-hydroxyphenyl)acetic (p-HPhAA), 3-(4-hydroxyphenyl)lactic (p-HPhLA) acids close to the known concentration of these metabolites in the blood serum of patients with A) renal failure, B) sepsis, C) septic shock ( Table 1 ). The sorbent without a modifier and three types of sorbents with different content of the modifier PhPA were studied. A 1 ml aliquot of model solutions was added to each 1.5 ml Eppendorf tube with the sorbent for the sorption experiments, n = 3 for min, middle and max concentration. The weight of the sorbent was 0.053 ± 0.001 g. The mixture was shaken for 30 min, the supernatant was taken for analysis by liquid-liquid extraction and gas chromatography-mass spectrometry. The degrees of the sorption of all sepsis-associated metabolites for the minimum and middle concentrations of the model solutions were more than 90%. Only at the maximum concentration of PhLA, p-HPhAA, p-HPhLA in solution and the maximum concentration of the PhPA modifier on the sorbent, sorption decreased slightly to 50-80%. In all modified sorbents, there was an easy and fast desorption of PhPA from the surface of the sorbent into the solution. The studied modified sorbent demonstrated in vitro ability to perform the function of purifying the blood from toxic sepsis-associated compounds, and simultaneously it can serve as a carrier for the delivery of missing metabolites to the body. Between baseline and TOC, mean hemoglobin level increased from 9.6 to 9.9 g/dL in the CFDC arm and from 9.0 to 9.5 g/dL in the BAT arm (Fig. 1) . Changes in all four specific iron homeostasis parameters between baseline and TOC were similar between treatment arms (Fig. 1) . Conclusions: CFDC therapy did not lead to increased anemia or reduced serum iron level in patients with serious CR infections. (Fig. 1) . These results remained significant in all sensitivity analyses. Conclusions: Oliguria lasting more than 12 h (KDIGO stage 2 or 3) has major diagnostic and prognostic implications, irrespective of sCr elevations. Level 1 was noted in 3 cases (11.54%) and Level 2 in 6 (23.08%). Serious AKI -14 patients (53.85%) and 4 of them needed renal replacement therapy. We did not find differences in preoperative creatinine levels. Patients did not differ according do age sex and BMI between groups. Group C subjects more often suffer from pulmonary hypertension (9 vs 3 p = 0.146) and diabetes (5 vs 1 p = 0.123), but it does not reach statistical significance. In group C additionally operation tends to last longer, be more often performed with the use of cardiopulmonary bypass and patients need more transfusions. Conclusions: It seems to be probable that pulmonary hypertension and diabetes could be significant risk factor of high-grade acute kidney injury development after lung transplantation. Identification of factors modifying renal insufficiency development in lung transplant recipients needs further investigations. Methods: Critically ill patients with acute renal failure and need of CVVHD were included. Patients received 5 g fosfomycin over 120 min every 6 h intravenously. PK was measured two times for each patient, once with CVVHD and once without. Model development and simulation was performed using non-linear mixed effects modelling (NON-MEM ® V.7.4.3). Results: Two of 15 patients were female. Median (range) age was 57 (49-80) years. Six patients were anuric. Creatinine clearance (CRCL) ranged from 5.89 to 210 ml/min for patients retaining urine production. 300 blood samples were collected in total. A two-compartment model with zero-order input and inter-individual variability on intrinsic clearance (CLRENAL) and volume of the central compartment (Vc) was used. An additional dialysis clearance (CLCVVHD) was incorporated. CRCL accounted for the variability on CLRENAL. VC increased linearly with time after first dose. Population estimates were 0.34 l/h for CLRENAL, 18.1 l for VC at first dose, 4.89 l/h for intercompartmental clearance and 19.7 l for volume of the peripheral compartment. Simulations on basis of the model showed that approved daily doses of 12 to 24 g intravenous fosfomycin in two or three daily doses do not result in critical accumulations within five days after the first dose in anuric patients with and without CVVHD. For patients with CRCL > 50 ml/min and CVVHD, dosage should be increased to at least 15 g fosfomycin in three daily doses. Conclusions: Model based simulations reveal a safe and effective use of the approved fosfomycin dosing regimens against bacteria with minimum inhibitory concentrations up to 64 mg/l in critically ill patients with and without CVVHD. Introduction: Regional citrate anticoagulation (RCA) is recommended as first line anticoagulation for continuous renal replacement therapy (CRRT). Studies report variable filter life despite optimal citrate protocols. The aims of this study were i) to investigate whether citrate affects thrombin generation, fibrinolysis and platelet function, and ii) to explore whether systemic blood samples are representative of intracircuit clotting parameters. Methods: We screened critically ill patients who were prescribed CRRT for acute kidney injury (AKI). Patients with known thrombotic or bleeding tendencies and patients who had been prescribed blood products or other anticoagulants were expluded. In eligible patients, we measured coagulation parameters at baseline (pre-CRRT), followed by serial measurement of thrombin generation, D-dimer and platelet function during CRRT for up to 72 h. We also compared samples taken from the arterial line with paired samples taken directly from the circuit. Results: A total of 11 patients were recruited (mean age 62.4, 82% male). At baseline, all patients had Factor VIII and von Willebrand Factor concentrations above Reference range and also significantly increased peak thrombin generation. During CRRT, there was no significant variation in systemic maximum peak thrombin generation, time to peak thrombin generation, fibrinolysis and platelet function analysis. There was no significant difference between paired samples taken from the arterial line and the circuit. Introduction: Valproic acid (VPA) is moderately dialyzable in case of overdosing. In vitro data show effective removal with a hemadsorbent system [1] . We report the first successfully treated clinical case of a lethal VPA intoxication with CytoSorb ® (CS) hemadsorption after an intermittent hemodialysis (IHD) session. A 54-year-old male was admitted to the emergency department following auto intoxication with VPA, lorazepam and olanzapine. He was intubated because of lowered mental status (GCS 4). First measured VPA plasma concentration was 1320 mg/l with a free fraction of 1012 mg/l. IHD was commenced for 4 h. As VPA remained at toxic levels, a citrate-anticoagulated continuous veno-venous hemodialysis (CVVHD) circuit was initiated with a CS cartridge installed in pre-hemofilter position. Blood samples were collected at the adsorber in-and outlet to evaluate VPA plasma levels. Results: At the start of CVVHD and CS therapy, VPA bound and free fraction plasma levels where 525 mg/ml and 335 mg/ml respectively. Combined treatment resulted in a decline to 50 mg/ml and 0 mg/ml over the course of 30 h (Fig. 1) . A total of 3 adsorbers were used. CS showed saturation in approximately 3 h. On day 3 our patient was awake and extubated successfully. He was discharged to the psychiatric ward for further treatment. Conclusions: Combined CVVHD and CS hemadsorption therapy is an effective add-on treatment for life-threatening VPA intoxication. Patient written informed consent was obtained for publication. (Fig. 1) . Conclusions: Despite the limited number of studies, this analysis indicates that CS may reduce NE needs in vasoplegic shock patients. Hemodynamic stability could be a novel endpoint to assess hemoadsorption efficacy in future trials. Introduction: RRT with adsorbing membranes is used in septic shock with AKI, but the anti coagulation may be problematic when a proinflammatory and anti-fibrinolytic response is present. Aim of this study is: 1-to evaluate the changes of plasminogen activator inhibitor 1 (PAI-1), a key suppressor of fibrinolysis, during RRT with an adsorbing membrane; 2 -the time course of the thromboelastographic parameters. Methods: Thirty patients with sepsis and AKI were submitted to RRT with the adsorbing membrane oXiris (Baxter, USA) in CVVHDF mode integrated into the Prismaflex platform (Baxter, USA). Pre-filter citrate was used as loco-regional anticoagulation. In all the patients arterial and post-filter TEG was performed at basal time (T0) and at 24 h of treatment (T1) and an arterial sample was obtained to calculate plasmatic PAI-1 (Elisa method) at the same times. All data are expressed as mean and SD or median and IQ. For comparison beween data T test student or non parametric test were used. The significance level was p < 0.05. Results: All the treatments were completed without major complications. Arterial TEG parameters did not change from T0 to T1 and were in the normal range, whereas post-filter TEG parameters parameters had longer R time and reduced MA amplitude. Plasmatic PAI-1 decreased from 46 ± 30 to 17 ± 10 ng/ml (p < 0.05). Conclusions: PAI-1, a key suppressor of fibrinolysis, may decrease durng CRRT with the membrane oXiris. This may improve the anticoagulant response of the filter without negatively affect the patient coagulation. Introduction: Previous studies demonstrated neutrophil extracellular traps (NETs) formation augmented during COVID-19 and the levels of circulating NETs-derived molecules correlated to the severity of COVID-19. We hypothesized that removal of circulating NETs-derived molecules from the bloodstream could be an effective strategy to reduce dysregulated inflammation in COVID-19. In this study, we examined whether treatment with direct hemoperfusion with polymyxin B (PMX)-immobilized fiber column (Toray Industries, Japan) can limit the progression of COVID-19. Methods: We studied, 30 COVID-19 ARDS patients, who required admission to the ICU and mechanical ventilation from August 2020 to June 2021. Thirteen patients received PMX hemoperfusion within 12 h after ICU admission and blood samples were taken from them before and immediately after hemoperfusion. Plasma levels of NETs-related products including myeloperoxidase-DNA, neutrophil elastase-DNA, and cell free-DNA were measured. Results: Plasma levels of NETs-related products collected at ICU admission increased in COVID-19. This result suggests that NETs would be accelerated by COVID-19. When plasma levels of NETs-related products and cytokines were measured before and after PMX, the former significantly decreased after PMX, whereas the latter did not change. Time-course change in lymphocytes count without PMX significantly decreased at 5-7 days when compared with 0-1 days. On the other hand, patients who were treated with PMX lymphocytes counts significantly increased at 5-7 days compared with patients without PMX. Conclusions: We demonstrated that PMX membrane can effectively capture various nucleus-derived molecules. Furthermore, scavenging nucleus-derived molecules by treatment with PMX inhibited the progression of lymphopenia. Removing systemic nucleus-derived molecules from circulation by PMX may ameliorate irrelevant inflammatory and thrombotic complications in patients with COVID-19. Introduction: CytoSorb is a cytokine adsorption device that received FDA Emergency Use Authorization (EUA) for use in critically ill COVID-19 patients. The CTC Registry was established to collect patient-level data from U.S. centers using CytoSorb under the EUA. Methods: Consecutive patients on ECMO treated with CytoSorb were included. Retrospective data collection included demographics, comorbidities, COVID-19 medications, inflammatory biomarkers, and details on ECMO and CytoSorb use. Study follow-up was to hospital death or discharge. Primary outcome was ICU mortality. Comparisons between survivors and non-survivors were performed to evaluate predictors of mortality. Up-to-date information from the international Extracorporeal Life Support Organization (ELSO) ECMO COVID-19 Registry was considered to help contextualize the results. Results: Fifty-two ECMO patients treated under EUA from April 2020 to April 2021 were enrolled from 5 U.S. centers. Baseline characteristics were comparable to the ELSO Registry except for higher rates of obesity in the CTC cohort. ICU mortality rates in the CTC cohort were 17.3% at 30 days, 26.9% at 90 days, and 30.8% overall. Gender, age, baseline SOFA, baseline D-dimer levels, and CytoSorb use between survivors and non-survivors are shown in the Table. Regression analyses suggested a borderline association between baseline D-dimer levels and mortality, with 32% increase in the risk of death per 1 µg/ ml increase (p = 0.055). CytoSorb was generally well tolerated without any unanticipated device-related adverse events reported. Conclusions: Combined use of ECMO and CytoSorb in critically ill COVID-19 patients was associated with mortality rates that compared favorably to international benchmarks. Elevated baseline D-dimer levels appeared to be associated with increased risk of mortality. Introduction: Emergency pediatric airway management and intubation require the completion of multiple individual tasks, under time pressure, with a high cognitive load, prone to error. The Pediatric Structured CRitical Airway Management (SCRAM) bag has been designed to rationalise and standardize the approach to pediatric airway management. We hypothesized that the use of the SCRAM bag in hospital on first exposure, with no prior training would perform at least as well as standard practice. Methods: Twelve participants, comprising a combination of anesthetic registrars, operating department practitioners and pediatric emergency department nurses, were randomized into two groups and asked to prepare a 'kit dump' for a simulated pediatric emergency using either a standard resuscitation trolley or the SCRAM bag. Following at least a 2-week wash out period, each participant completed a second simulation using the alternative equipment set. The primary outcome measured was time taken to kit dump completion. Secondary outcome measures were the number of errors and self-reported cognitive load. Results: Use of the SCRAM bag resulted in a shorter time to kit dump completion (95% confidence interval: 44.5 + 35.6; 8.9 to 80.1 s). This is an average reduction of 11.5%. 20% fewer errors and an average of 9.8% reduction in cognitive load were observed in the SCRAM group. Conclusions: This study demonstrated that the SCRAM bag performed as well as established emergency airway preparation systems in the hospital setting. The SCRAM bag did not increase time to readiness nor increase errors, despite this being the first exposure with no prior training. This highlights ease of use which provides the user with the advantages of equipment standardization, portability and cognitive aids integrated within the SCRAM system. Introduction: High-flow nasal cannula (HFNC) therapy can reduce the need for mechanical ventilation and seems to lower mortality rates in patients affected by Coronavirus disease 2019 (COVID-19) with hypoxemic respiratory failure (HRF). However, the effectiveness of HFNC therapy on mortality in these patients with a Do-Not-Intubate (DNI) order is unclear. Purpose: Assess mortality in patients affected by HRF due to COVID-19 with a DNI order treated with HFNC. Identify predictive factors for mortality in this cohort. Compare the use of HFNC and mortality between a first and second pandemic wave of COVID-19. Methods: We retrospectively analyzed the medical records of all COVID-19 patients with a DNI order that received HFNC in UZ Brussel between March 6, 2020, and the January 1, 2021. Besides 30-day mortality, we focused on APACHE III score and P/F ratio at the start of HFNC. Furthermore, to evaluate an evolution in HFNC use, a comparative analysis was made between patients treated during the first and the second COVID-19 wave. Results: A total of 57 patients treated with HFNC had DNI orders with a 30-day mortality of 84%. Higher APACHE III and lower P/F ratios at the start of HFNC were predictors for mortality. APACHE III scores higher than 47 had a positive predictive value for mortality of 97%. Survivors had a median APACHE III score of 45 (IQR 40-48). In the first wave, the duration of HFNC therapy was 3 (IQR2-5) vs. 6 (IQR3-10) days in the second, p = 0.005. Mortality was comparable 85% vs. 84%. Conclusions: COVID-19-patients with HRF and DNI orders treated with HFNC have high mortality. Patients in the second wave received significantly longer HFNC therapy compared to the beginning of the COVID-19 pandemic, without improved survival. APACHE III at the start of HFNC is an early predictor for mortality with a high positive predictive value. In high APACHE scores with DNI orders, palliative care should be considered, as prolonged HFNC therapy does not improve the outcome. Introduction: Aerosols are only generated by specific medical interventions like bronchoscopy. Initial recommendation in the SARS COV 2 pandemic was to avoid invasive procedures such as bronchoscopy by the risk posed to the operator [1, 2] , especially in the first days of ICU admission, that the viral load is postulated is greater. Objective: The aim of the present study is to analyze the risk to the healthcare provider of perform fibrobroncoscopy in mechanically ventilated patients with SARS-CoV-2 pneumonia. Methods: Observational, single-center study. Fiberoptic bronchoscopy was performed in pressure controlled ventilation mode maintaining the optimal PEEP previously established. All broncoscopies were performed by an intensivist, a nurse and a nurse assistant, all of them equipped with individual protective equipment. Time of study was from March 2020 to October 2020. Clinical followup of the healthcare providers was conducted exploring the onset of symptoms such as fever, headache, anosmia. Testing were available widely to symptomatic health-care workers and auxiliary acute health-care staff. In case of clinical suspicion of infection RT-PCR for SARS-CoV-2 were performed. Results: A total of 119 bronchoscopies were performed in 81 mechanically ventilated patients during the time of study. Mean duration of procedure with the airway occupied by the bronchoscope was 2 min and 18 s, performed by a professional with proven experience in this field. Only four healthcare workers developed non specific symptoms in first 48 h after procedure. RT-PCR for SARS-CoV-2 resulted negative in all of them. Conclusions: Exposure to any aerosol-generating procedures with adequate individual protective equipment and minimizing procedure times turned out to be a safe procedure for healthcare workers in mechanically ventilated patients. We collected data about the timing of sedation, drugs used and dosage, level of sedation, procedure success/failure, complications, patient's explicit memory, and comfort. Results: A-VDL was successful in all the patients: 23 were allocated to A-VDL intubation and 1 to A-videobronchoschopic intubation due to an A-VDL Cormack-Lehane score of 4. We identified 4 procedural times (T0-T3). At T0, all patients received dexmedetomidine (see Table 1 ) and local anesthesia (LA) followed by a deep pharynx exploration as "topicalization effectiveness test". At T1, 22 patients had fentanyl, and 14 a subanesthetic dose of ketamine; at T2 local anesthesia was also nebulized directly on the vocal cords/trachea in A-VDL in all patients. At T3, 9 patients had a subanesthetic dose of propofol (before tube passing). The median Ramsey and RASS score were 3 and -1 respectively. The mean time from T0 to intubation was 22 min. When asked, 4 out of 13 patients recalled intubation and 1 out of 14 reported pain, while 3 out of 14 complained of mild discomfort. None required atropine. One patient had a transient oxygen desaturation after successful A-VDL. Patients receiving ketamine became less cooperative. In this case series, A-VDL was successful and well tolerated. Dexmedetomidine at a higher dosage than previously reported (mean 1.48 mcg/kg), together with a low dose of fentanyl, safely granted in this study the desired level of sedation while maintaining spontaneous breathing and cooperation. Introduction: Airway compromise involving the formation of a tracheostomy is a significant cause of mortality in the ICU [1] . The COVID-19 pandemic saw an increase in NAT doctors re-deployed to ICU, bringing its own challenges. This quality improvement project aimed to assess the impact of simulation training on the confidence of NAT doctors to manage tracheostomy emergencies. A self-assessment survey and multiple-choice questionnaire (MCQ) were distributed to NAT doctors in a tertiary center ICU to assess their confidence and knowledge in managing a tracheostomy emergency. They were subsequently invited to participate in simulation sessions based around the National Tracheostomy Safety Project algorithm [2] . Management of a tracheostomy emergency up to the point of primary oxygenation was demonstrated on a simulation dummy. Participants then ran through scenarios including blocked and displaced tracheostomy tubes. Trainees completed the same MCQ and survey post-intervention. The aims were to train a minimum of 80% of our NAT doctors in the ICU and increase the average confidence score to manage an emergency to ≥ 3/5 (on a Likert scale 1-5: 1 = not at all confident/familiar, 5 = very confident/familiar). Methods: This was a prospective observational study was conducted between April 01, 2020 and April 31, 2021 in our ICU. Patients were monitored clinically and with serial arterial blood gas analysis. NIV was started with initial inspiratory positive airway pressure (IPAP) of 6-8 cm of H2O and was gradually increased to achieve clinical response. The success of NIV, duration of NIV use, hospital mortality, and improvement in clinical parameters were assessed. The failure of success of NIV was defined as a subsequent requirement of invasive ventilation. Results: A total of 64 patients were included. The mean age of the study population was 62 years. 34 were men. Community-acquired pneumonia (83%) and pulmonary edema (17%) were the most common causes of respiratory distress. The ARDS criteria were found in 45 patients. NIV was used in 54 patients (84.3%), NIV with prone in 47.2% and NIV with High Flow Nasal Cannula (HFNC) in 38.9%. The use of NIV was failed in 25 subjects, while 32 subjects required intubation with an average delay of 4 days. The mortality rate was 31% with positive correlation with NIV failure. Pao2/Fio2 ≤ 100 (p = 0.02), comorbidity (p = 0.01) and ICU delay admission ≥ 7 days (p = 0.038) and acute renal injury (0.01), are significantly associated with NIV failure. The use of prone position and HFNC combined with NIV decrease significantly endotracheal intubation. In COVID-19 patients with acute hypoxemic respiratory failure, NIV is feasible can decrease the rate of tracheal intubation and mortality particularly if combined with prone and HNFC. Introduction: Tracheal intubation in critical care is well recognized as a high-risk procedure, meticulous preparation and effective team working are determinants of good outcome. Checklists aid structured preparation and execution of procedures. We aimed to adapt our unit intubation checklist [1] for use on mobile devices to ensure a consistent safety standard for intubations both on the unit and elsewhere in the hospital. Methods: The unit intubation checklist covers different aspects of preprocedure preparation, each aspect was assigned one page. Using Affinity Publisher (Serif Europe Ltd., West Bridgford, UK), the different components of each aspect were laid out and supplemented by pictograms, arrows and formatting to aid visual reception. Interactive elements were then added using Adobe Acrobat X Pro (Adobe Inc., San Jose, California, US). We sought feedback from multiple clinicians at different training levels and improved the checklist iteratively in response to their input. The resulting PDF document contains eight pages in a 16:9 format suitable for most modern smartphones (Fig. 1) . Viewing is intended in the Acrobat app (Adobe Inc., San Jose, California, US), with one-page display and sideways swiping allowing a view of each page in its entirety and quick progress through the checklist. Each page uses a characteristic background color, with large page numbers in the upper right corner. Seven of the pages contain interactive elementscheckboxes to aid completion of all checklist steps and radio buttons on the airway assessment page to aid identification of high-risk features, and a link to the published guideline on the title page. Conclusions: This interactive mobile checklist has been described as useful and easily adopted in clinical practice from initial feedback. After rolling out this checklist broadly, the impact on checklist uptake and rate of clinical incidents will be the subject of subsequent work. Introduction: Extubation requires disciplined practice to sustain patient safety during de-escalation from artificial support. We aim to evaluate extubation practice and risk perception around extubation to plan our implementation of extubation care bundle. Methods: Retrospective analysis of electronic notes for procedural documentation and post-extubation complications from two 3-month periods in 2019-2020 was conducted. Pediatric intensive care staff survey on extubation practice was reviewed. Results: Of 114 extubation events for 106 children (median age 6 months, range 1 day-16 years), procedural documentation present in 75% (n = 85) medical and 96% (n = 109) nursing notes. 68% (n = 77) extubations occurred daytime (09:00 h-19:00 h) and 13% (n = 15) night-time (22:00 h-07:00 h). Unplanned extubation rates were 1.7 and 0.9/100 endotracheal tube days for 2 periods, with 2 events of resuscitation for emergent re-intubation. Incidence of post-extubation stridor requiring treatment was 31% (n = 36), and 12% (n = 14) for desaturation over 10% from baseline. 38 extubations transitioned to non-invasive ventilation, of which 4 (11%) escalated to invasive ventilation by 12 h. 48-h freedom from re-intubation was 94% (n = 107). 36 (47% nursing, 53% medical) staff completed questionnaires. Stridor and desaturation were perceived as "often-to-always" events by 16% and 8% staff respectively. Staff rated unorganized or chaotic experience as "often-to-always" related to resource factors (readiness of airway management equipment,71%, or verbalizing failure plan, 37%) or team factors (communication, 74%, role clarity, 69%, or night-time extubation, 26%). Conclusions: Post-extubation complications appeared less infrequent than perceived and risk perceptions are a critical determinant of change in clinical practice. Hence, we are targeting interventions that will engage and change risk perceptions to produce subsequent positive changes in extubation practice. Introduction: Endotracheal intubation (ETI) is an aerosol-generating procedure with high risk of clinician exposure and infection by SARS-CoV-2. Protective barrier enclosures have been found to complicate ETI and prolong intubation times, posing a potential threat to patient safety. We designed a novel barrier mouthpiece (Airway Shield) for use during ETI, to reduce risk of clinician exposure to airborne pathogens without complicating the procedure. Our study aims to demonstrate Airway Shield's efficacy in reducing airborne particle exposure in a preclinical model. We performed a preclinical simulation trial of ETI using a C-Mac videolaryngoscope in manikin models to evaluate laryngoscopist exposure to airborne particles (droplets (> 5 microns) and aerosols (< 5 microns)) with and without 3-D printed prototypes of Airway Shield (Fig. 1) . A self-contained clinical simulation lab and a manikin (AirSim, TruCorp ® ) with droplet and aerosol-generating equipment using normal saline were used for simulation. Airborne particle generation during intubation was measured in 2 clinical scenarios (CPR and high-flow nasal oxygen (HFNO)) during induction, initial laryngoscopy, and endotracheal tube placement. ImageJ software was used to estimate airborne particle dispersion using automatic pixel quantification applied to manually selected polygonal areas. Student's T-test was used to compare averages. A p value of < 0.05 denoted statistical significance. The highest risk of exposure to airborne particles for all scenarios was observed during induction. Overall, Airway Shield demonstrated significant average reduction of airborne particles compared with standard intubation (6108 vs 122,027; p = 0.0149). The greatest reduction in aerosol counts was seen during induction in the CPR scenario (3047 vs 24,001) and during induction in the HFNO scenario (78 vs 37,142) for droplet counts. Conclusions: In a preclinical model, Airway Shield proves effective at reducing the risk of clinician exposure to droplets and aerosols during ETI. Results: Based on the patient's data collected for the month of May up to October 2020, 82% of COVID-19 patients who used CPAP therapy outside ICU improved their oxygenation, while about 18% of them showed no signs of improvement then later intubated. On the first three months of the study, success rate in improving oxygenation of patients after using CPAP were between 91-95% (Fig. 1) . The success rate eventually drops significantly on month of August and September due to surprising increase of COVID-19 cases which overwhelms the number of RT staff assigned and also the supply of proper mask sizes became scarce. Not long enough, additional RT staff were trained and assigned to COVID-19 patients and arrival of mask supplies late-month of September that causes rebound in success rate to 75% on month of October. Conclusions: Improvement of oxygenation in COVID-19 patients using non-invasive ventilation is critical prior to patient deterioration and requires proper management of trained healthcare personnel and availability of resources. Fig. 1 . Overall, despite the limited and conflicting guidance, we were reassured that our practice had not deviated from standard care due to fears around aerosolisation and risk of staff transmission. The results show a decreased age and a higher positive end-expiratory pressure (PEEP) at the time of tracheostomy in the COVID-19 cohort, suggesting that tracheostomies can be safely performed at PEEP values higher than 5. Results: Depending on the severity of the condition SpO 2 values could reach 95% after 1-2 sessions in moderately severe patients and after 5-6 sessions in patients in severe condition. This circumstance made it possible in most cases to refuse additional oxygen therapy during the HBO course or within 1-2 days after its completion (Fig. 1) . In no cases it was necessary to put patient to mechanical ventilation. In addition, against the background of HBO, the normalization of the redox state (malonic dialdehyde concentration, blood serum total antioxidant activity, platinum electrode open circuit potential in blood serum) was noted [4] . There was a significant difference in the NEWS2 scale: 4.7 ± 2.3 and 4.0 ± 2.3 points on days 4 and 10 in the control group, 4.3 ± 2.2 and 1.2 ± 1.7 points before and after the HBO course in the study group. Conclusions: HBO can be an important addition to the complex treatment in patients with COVID-19 by eliminating hypoxia, reducing the risk of switching to mechanical ventilation and significantly improving patient condition. -19) is unclear. The primary objective of this study was to explore the role of prolonged high flow nasal cannula (HFNC) oxygen therapy on mechanical ventilation and mortality in patients with ARDS caused by CoViD-19. Furthermore, predictors for the need for mechanical ventilation and mortality were investigated. Methods: A retrospective observational study was conducted at a mixed tertiary ICU in Brussels. Medical records were reviewed of all consecutive CoViD-19 patients presenting with acute hypoxic respiratory failure treated with HFNC oxygen therapy between March 6th, 2020, and January 1st, 2021. Delayed intubation or prolongation of HFNC therapy was defined as the number of days of HFNC from the point when a respiratory rate oxygen index (ROXi, defined as the ratio of SpO2/FiO2 to respiratory rate) < 3.85 was reported. Results: One hundred and twenty patients received HFNC therapy, and fifty-four (45%) were successfully weaned. Thirty-six (66%) of them reached the HFNC prolongation criteria. Seventy-five patients underwent MV with 40% mortality. Higher Apache III and SAPS 2 scores were predictive factors for mortality, while prolonged HFNC treatment was not. Prolongation of HFNC therapy was a negative predictor for MV after adjustment for age, sex, and comorbidities. Conclusions: In the current cohort, prolongation of HFNC therapy and subsequently delayed intubation resulted in a lower rate of MV and was not associated with higher mortality. APACHE III and SAPS2 at admission were early predictors for MV and mortality. Introduction: Our objective was to identify factors associated with mortality after the first 24 h of prone position in patients on mechanical ventilation due to moderate and severe ARDS caused by SARS-CoV-2. Methods: This was a retrospective cohort study. We included all patients with ARDS causedby SARS-CoV-2 pneumonia and required prone. We registered sex, age, APACHE II, SOFA, number of prone sessions-which lasted 24 h-, hospital-acquiredinfections and hospital mortality. PaO 2 /FiO 2 , plateau pressure and driving pressurewere recorded and compared before and after the first prone session. Results: A total of 126 patients were included. Mean age was 60 ± 15 years, 25% were women. APACHE II was 12 ± 2. Baseline PaO2/ FiO2 112 ± 26 mmHg with no differences between survivors and nonsurvivors (p = 0.92) and after prone it was 186 ± 59 (p < 0.000). Survivors had 220 ± 48 mmHg versus 169 ± 57 in non-survivors (p < 0.000). One prone session was required by 67 patients, 2 sessions by 26 patients, 3 by 23 patients and 4 by 10 patients. Mortality was 55%, 69%, 75% and 100% respectively; p < 0.000). 117 patients increased PaO 2 /FiO 2 . In 21 patients (16%) it was less than 25%; 28 patients (22%) showed a rise between 25-50%; and in 68 patients (54%) more than 50%. Mortality was 90%, 68% and 53% respectively (p = 0.012). 52 patients had suspected intra-hospital infection. 10 survived (20%) and 42 died (80%) (p < 0.001). After multivariate analysis, factors independently associated with mortality were % of increase in PaO 2 /FiO 2 after 24 h in prone (OR 0.99; CI 95% 0.98-0.99; p = 0.01) the number of prone cycles (OR 1.84; CI 95% 1.08-3.12; p = 0.02) and presence of inhospital infection (OR 5.8; CI 95% 1.78-2; p = 0.001). Conclusions: In this cohort of patients with ARDS secondary to SARS-CoV-2 pneumonia, the increase in PaO 2 /FiO 2 ratio after 24 h of prone position was independently associated with decreased mortality; while number of prone cycles, and presence of hospital-acquired infection were associated with increased mortality. Introduction: One of the devices most used in patients with severe respiratory infection caused by SARS-Cov2 has been HFNC (high flow nasal cannula), with the aim of preventing progression to IMV. It is important to have scores that allow predicting the success or failure of this therapy, avoiding unnecessary delays in the initiation of IMV. Methods: To assess the prognostic capacity of the ROX Index in patients with severe respiratory infection due to SARS-Cov2 with HFNC. We evaluated 20 patients admitted to the ICU for severe respiratory infection with CRP + SARS-CoV-2 who required respiratory support on admission with HFNC. The following variables were collected: demographic data, ROX index at admission, 12 h, 24 h, 36, 48, 60 and 72 h, duration of NFNC, need for invasive mechanical ventilation, stay in ICU, mortality in ICU. Results: The mean age was 63.9 years ± 11.5. 85% males. The median time of HFNC was 4.5 days. The mean stay in the ICU was 12 days ± 6.9. 65% required invasive mechanical ventilation. Mortality was 50%. Patients who required invasive mechanical ventilation had lower ROX index values in the first 48 h compared to the group that did not require MV, however, we did not find a statistically significant association (95% CI p > 0.05). The patients who required mechanical ventilation presented higher mortality with significant differences (95% CI p = 0.029). We did not observe differences in mortality associated with the duration of previous HFNC in patients who required IMV. Conclusions: We observed an adequate correlation between the ROX index and HFNC failure in patients with severe respiratory infection due to SARS-CoV-2. Introduction: Preclinical studies have demonstrated that mechanical ventilation (MV) is associated with brain injury. Glial fibrillary acid protein (GFAP) is an accepted serological marker for brain injury. We evaluated whether diaphragm neurostimulation in synchrony with lung-protective MV for 50 h, in a normal-lung porcine model, would affect GFAP serum concentrations in comparison with never-ventilated and mechanically ventilated pigs. Methods: Twenty-eight healthy juvenile pigs with non-injured lungs were divided into four groups: MV only (MV group, n = 8), MV in association with diaphragm neurostimulation delivered every other breath (TTDN50% + MV group, n = 7), MV in association with diaphragm neurostimulation delivered every breath (TTDN100% + MV group, n = 7) and never ventilated (NV group, n = 6). A central line catheter with embedded electrodes was inserted into the left subclavian vein for the TTDN50% + MV and TTDN100% + MV subjects, and the diaphragm was activated by temporary transvenous diaphragm neurostimulation (TTDN), targeting a reduction in pressure-time product between 15 and 20%. Volume control MV was set to achieve and maintain a tidal volume of 8 ml/kg with a PEEP of 5 cmH 2 O. Blood samples were collected at the end of the experiment, to analyze GFAP serum concentrations. Data are expressed as median and interquartile ranges. The Kruskal-Wallis test and Dunn's multiple comparison test were used for statistical analysis. P values < 0.05 were considered statistically significant. Results: GFAP serum concentrations found were: 0.40 ng/ml (0.28-0.57) for the MV group, 0.29 ng/ml (0.25-0.32) for the TTDN50% + MV group, 0.04 ng/ml (0.02-0.06) for the TTDN100% + MV group, and 0.15 ng/ml (0.07-0.23) for the NV group, with statistically significant differences between groups, as determined by the Kruskal-Wallis test, p < 0.0001. Conclusions: In a porcine model, TTDN + MV for 50 h resulted in lower GFAP serum concentrations in comparison with the MV group, with a dose-dependent effect. Introduction: We investigated whether there were any predictors of poor outcome amongst patients who were admitted to the intensive care unit (ICU) following treatment with high-flow nasal oxygen (HFNO) in Medical HDU (MHDU) at a tertiary hospital in Glasgow. Delayed intubation as a result of initial treatment with HFNO has been shown to worsen ICU outcomes, including mortality, extubation success and length of ventilation [1] . Identification of factors that predict poor ICU outcome during HFNO therapy could aid decision-making regarding escalation and timing of intubation to avoid delayed intubation. Methods: Between January 2016 and January 2019, there were 106 patients admitted to MHDU who were treated with HFNO, deteriorated and were admitted to ICU. Data were collected from the patient record, including demographics and physiological parameters. Severity of respiratory failure was calculated using the ROX index [2] , measured after one hour of HNFO therapy and immediately prior to ICU admission. Chisquare tests were conducted to assess whether demographics, length of HFNO therapy or ROX index were associated with poor ICU outcome. Results: The majority (62%) of patients were male and median age was 59 years. Median MHDU length of stay was 0.79 days (IQR 0.34-1.91) and patients received a median of 12 h HFNO (IQR 5-29.5 h) prior to admission to ICU. Once admitted to ICU, 85.8% received invasive ventilation. Hospital mortality was 43.4%. In a regression analysis, only age and quartile of ROX index at ICU admission were significantly associated with ICU outcome, with p values of 0.009 and 0.03 respectively. Conclusions: Age and low ROX index on admission to ICU are predictors of poor outcome in patients admitted to MHDU receiving HFNO. twelve and twenty four hours [1] . An NHS safety alert (2015) identified 76 reported incidents in England [2] . The Humidicare (Medovate, Cambridge, UK) warns of an impending problem by reacting to the heated humidifier (HH) with a color change and caution message. Removal of the Humidicare is prompted before waterlogging occurs. We evaluated device ability to deliver. Warning within the relevant timeframe and to ensure immunity to heat and humidity from a simulated patient. Methods: We performed a randomized study in a simulated ICU environment using a Maquet ventilator and mechanical lung. Time to Humidicare warning delivery in a HH circuit (n = 10) was compared to behaviour in a control circuit without HH (n = 10). Fisher & Paykel HHs were used. A secondary HH on the lung side emulated patient behaviour to demonstrate no confounding factors. Results: All HMEs activated in HH arm. Color change started after a mean of 31.4 s ± 2.76 s (95% CI). The warning message was fully developed after a mean of 93.6 s ± 8.09 s (95% CI). No HMEs were triggered in the control arm after five minutes. Conclusions: The Humidicare HME seems to reliably indicate the problem in a timely manner. It does not register false positive with the heat and humidity coming off a patient equivalent. Occasional errors are hard to eliminate with traditional information dissemination techniques and training; improved response is achieved with engineered solutions [3] . The Humidicare protects staff and patients by helping comply with NHS safety standards to prevent errors. COI: Young: share of patent ownership. Introduction: Silent hypoxemia (SH) is defined as severe hypoxemia without an increase in respiratory effort. This phenomenon is reported as highly prevalent in COVID-19 patients. The aim of this study was to determine the prevalence and the risk factors of SH in COVID-19 ICU population. Methods: This was a retrospective analysis of institutional database of COVID-19 patients treated in the ICU during the year of 2020. The SH was defined as a respiratory rate below 20 bpm and by two groups of PaO 2 /FiO 2 ratio: ≤ 300 to 200 (indicating mild ARDS) and ≤ 200 (indicating moderate to severe ARDS) upon admission to the ICU; the latter was selected for further analysis. Demographic data, co-morbidities and other variables were entered into the regression analysis of SH risk factors. Statistical analysis was carried out with SPSS IBM v24. Results: A total of 228 patients were included in the study. 62.3% were women (n = 142), mean age of 61.52 (SD = 13.5), and APACHE II score of 13.42 (SD = 7.21). The prevalence of SH was 18.9% (n = 43) in mild ARDS group and 11.8% (n = 27) in severe to moderate ARDS group. Univariate regression analysis revealed count of days before admission to ICU (Exp(B) = 1.09 CI 95: 1.02-1.17, p = 0.013) and lymphocyte count (Exp(B) = 1.29 CI95: 1.01-1.67, p = 0.046) as risk factors of SH. Multivariate regression model of these determinants revealed count of days before admission to ICU (Exp(B) = 1.09 CI95: 1.01-1.17, p = 0.025) as an independent prognostic factor of SH. Further analysis of days before admission to ICU showed median of 12 [7.8-14.3] for SH group and median of 7.5 [4] [5] [6] [7] [8] [9] [10] [11] for non-SH group (p = 0.003), overall group -8 [4] [5] [6] [7] [8] [9] [10] [11] . Conclusions: SH is prevalent in COVID-19 patients and is dependent on the definition criteria. Prolonged disease course before ICU admission is an independent risk factor of SH. Performance of automatic endotracheal cuff management device U. Borg, K. Bull Medtronic, Boulder, USA Critical Care 2021, 25(Suppl 1): P163 Introduction: Effective control of endotracheal tube (ETT) cuff pressure (CP) is vital to airway management in intubated patients. CP must be kept within a therapeutic range to ensure adequate cuff seal and delivery of mechanical ventilation, while preventing against complications such as ischemia, aspiration, and stenosis [1] . The purpose of this study was to test the CP management device PBACC (Puritan Bennett Automatic Cuff Controller, Medtronic, Boulder, USA) and evaluate maintenance of cuff seal in an animal model during mechanical ventilation. Methods: Eight animals with tracheal sizes suitable for 5.0 to 8.0 mm inner diameter ETTs were intubated. The cuff was inflated to a pressure of 25-30 cmH2O, as recommended in instructions for use. Contrast media was applied above the cuff. CP was maintained using the PBACC and compared to a Reference pressure transducer. Animals were in supine position for 60 min, followed by lateral position for 60 min. Supine position was assumed again for 30 min, followed by opposite lateral position for 60 min. Fluoroscopy was obtained five minutes after position change and at the end of each position period. Images were examined for dye in the trachea below the cuff. Results: There were no statistical differences between the PBACC pressures and the Reference. No cuff leaks were detected on fluoroscopy. Conclusions: CP may change due to change in position, slow cuff leaks and other causes, making routine monitoring of CP necessary to maintain correct pressure. Automated cuff management devices have been suggested to remedy this situation. The PBACC maintained CP during all position changes resulting in no breach of cuff seal. These results may indicate that the PBACC device is suitable for continuous CP management. Longer-term clinical studies are needed to demonstrate its clinical utility. Introduction: Faced with a patient with difficult weaning, we must evaluate all the factors involved. Diaphragmatic dysfunction, due to injury or atrophy, plays a key role in these patients, so it is important to carry out an adequate assessment, for this we can use diaphragmatic ultrasound, which is a useful, non-invasive tool available at the bedside. We evaluated a 62-year-old patient with a history of hypertension, DM2 and obesity (BMI > 30) who was admitted to the ICU due to severe acute respiratory failure due to SARS-Cov2 requiring ECMO support with good evolution, currently in the weaning phase of respiratory support Percutaneous tracheostomy was performed due to difficult weaning. She is stable at the hemodynamic and respiratory levels, with a good level of consciousness (RASS 0), adequate cough, but with significant paresis due to prolonged mechanical ventilation. We monitor diaphragmatic mobility through ultrasound during the weaning process. Diaphragmatic ultrasound is performed at the level of the right hemithorax, at the 7-8th rib in the mid-axillary line. We monitor diaphragmatic mobility through diaphragmatic excursion. Conclusions: In this prospective cohort of spontaneously breathing patients affected by AHRF due to COVID-19 pneumonia, prone positioning was associated with an improvement in both gas exchange and respiratory mechanics. Widespread implementation of this easy to perform intervention could prove essential in improving critical care of non-invasively ventilated patients. Introduction: ECCO 2 removal may be useful in acute decompensated chronic obstructive disease and in ARDS to improve mechanical ventilation. ECCO 2 removal may be also combined with renal replacement therapy when AKI and respiratory failure coexist. Aim of this study is to quantify membrane lung CO 2 removal (VCO 2 ML) of two membrane lung oxygenators inserted in a RRT paltform. Methods: Fifteen patients were submitted to RRT combined with ECCO 2 R integrated into the Prismaflex platform (Baxter, USA). In 10 patients a 0.35 m 2 surface area polymetilpentene heparine coated hollow fiber membrane oxygenator (PrismaLung, Baxter, USA) was used. In five patients, a 0.8 m 2 surface area polimetylpentene and phosforilcoline coated membrane oxygenator was used (PrismaLung + , Baxter, USA). The RRT was CVVHDF mode and pump flow was gradually increased from 200 ml/min to 400 ml/min. Heparin was used for anti-coagulation. Arterial, pre-and post-oxygenator blood gas were obtained to calculated VCO 2 ML [1] . Results: All the treatments were completed without major complications. Pump flow was 350 ± 80 ml/min in all patients. Patients treated with PrismaLung and PrismaLung + had 10 and 7 VCO 2 ML measurements respectively. VCO 2 ML was 64 ± 24 ml/min in the PrismaLung patients and 104 ± 13 ml min in the PrismaLung + patients (p < 0.01). Conclusions: ECCO2R combined with RRT may be used safety in patients with AKI and respiratory failure. PrismaLung + seems to remove CO 2 better then PrismaLung, as reported from experimental data. Larger studies are warranted. Introduction: Patients in need of mechanical ventilation may suffer additional damage to the lungs from ventilator-induced lung injury (VILI) [1] . ACE inhibition was found to be beneficial, but its hypotonic effect impedes clinical application [2] . Here we tested, whether additional manipulation of the renin-angiotensin-system (RAS) by blocking aminopeptidases can alleviate this undesired effect. Methods: Anesthetized mice (C57/BL6, 18-28 g, 8-10 weeks) were mechanically ventilated with low or high tidal Volume (LVT, 6 ml/kg; HVT, 30 ml/kg) for 4 h, and treated with the ACE inhibitor Lisinopril (0.15 ug/kg/min) with or without aminopeptidase inhibitor (ALT00) at 2.7, 10 or 100 ug/kg/min. BALF was analyzed for inflammatory cytokine levels (IL-6, KC, MIP-2 and IL-1β) by ELISA. Mean arterial pressure (MAP) was measured continuously in the right carotid artery. Equilibrium concentrations of RAS metabolites in plasma were measured by LC tandem MS. Results: ACE inhibition decreased ventilation-induced inflammatory cytokines and MAP. Co-treatment with ALT00 reduced inflammation and increased dose dependently levels of Ang 1-7, an anti-inflammatory and anti-fibrotic RAS metabolite. Various doses had mixed effects of normalizing MAP and reducing cytokine secretion. Conclusions: Combined manipulation of the RAS system might represent a promising new treatment strategy for VILI requiring further mechanistic exploration. respiratory failure secondary to COVID-19, with indication for mechanical ventilation. Results: We analyzed the first four days of mechanical ventilation. On the first of starting mechanical ventilation, no significant difference was found in the ventilatory parameters of the surviving and non-surviving patients. on the fourth day, the variables under study were quantitatively higher in the group that died: FiO 35-10.18) . The trend of power, adjusted power, work and adjusted work is to increase between day 1 to day 4 in the group of those who died: 3.66 ± 7.85, 0.05 ± 0.12, 0.13 ± 0.50 and 0.01 ± 0.01, respectively. Unlike those who did not die, the trend of the variables is to decrease. Conclusions: The energy delivered to the respiratory system during mechanical ventilation was associated with mortality in our description, where despite initial protective parameters, ventilatory power and work increased during the first four days of ventilation in the deceased patients. Introduction: Up to 32% of patients with COVID-19 pneumonia may require ICU admission or mechanical ventilation [1, 2] . Data from lowand middle-income countries for COVID-19 ARDS are limited. Groote Schuur Hospital in Cape Town, South Africa expanded its ICU service to support patients with COVID-19 ARDS requiring invasive mechanical ventilation (IMV). We report on patients' characteristics and outcomes from two pandemic waves. Methods: All adult patients with COVID-19 ARDS admitted to ICU for IMV were included in this prospective cohort study. Data were collected from 5th April 2020 to 5th April 2021. Ethical approval was granted (HREC: 362/2020). Consent was obtained for survivors and waived for patients who died. Results: Over the 12-month study period, 461 patients were admitted to the designated COVID-19 ICU. Three-hundred-and-eighty patients met study criteria and 377 had confirmed hospital discharge outcomes. The median age of patients was 51 years (range 17-71), 50.5% were female and the median BMI was 32 kg/m2 (IQR 28-38). The median P/F ratio was 97 (IQR 71.5-127.5) after IMV was initiated. Comorbidities included diabetes (47.6%), hypertension (46.3%) and HIV infection (10.5%). Of the patients admitted, 30.8% survived to hospital discharge with a median ICU length of stay of 19.5 days (IQR 9-36). Predictors of mortality after multivariate analysis were: male (OR: 1.79), increasing age (OR: 1.04), higher SOFA score (OR: 1.29). Conclusions: In a resource limited environment, escalation of ICU IMV support achieved a 30.8% hospital survival in patients with COVID-19 ARDS. The ability to predict survival remains difficult given this complex disease. Introduction: PROSEVA proved that PP in severe ARDS reduces mortality without an increase in adverse outcomes. However, complications such as cannula displacement could be life-threatening, and the benefits of PP whilst on ECMO are yet to be proved. Our study aimed to assess safety of proning patients on VV-ECMO and try to identify signs of potential benefit of this therapy. Methods: Retrospective data collection from electronic Pt notes including: demographics; SARF aetiology; CT findings; indication; number of PP sessions; duration of ECMO and complications. Pre-and post-P/F ratio, ventilator and ECMO settings were compared. The data were analyzed using statistical software SPSS ® Results: Fifty-two ECMO Pts (71% male; 46 ± 14 years-old; BMI 29 ± 6 kg/m2) were PP from 2016-2021. 73% survived to ECMO decannulation and were discharged from our center. ECMO duration was 26 ± 18 days. The most frequent etiologies of SARF were community acquired pneumonia (38.4%) and COVID-19 pneumonitis (23.1%). CT chest prior to PP documented consolidation in 94.2% and bilateral infiltrates in 84.6% A high PEEP CT was performed in 16 Pts, showing recruitability in 81%. Most patients were proned for recruitment (32.7%) or due to refractory hypoxia (30.8%). Ventilator and ECMO support decreased with PP (FiO 2 on the ventilator 0.5 ± 0.2 vs 0.4 ± 0.2; p = 0.001; ECMO blood flow (4.4 ± 0.8 vs 4.2 ± 0.8 l/min; p = 0.006). A significant improvement in the following variables was seen after PP: lung compliance (19 ± 17 vs 25 ± 20 ml/cmH 2 0; p = 0.014), P/F ratio (137 ± 102 vs 180 ± 126; p = 0.001) and 100% test (17 ± 10 Kpa vs 31 ± 16 Kpa, p < 0.001). Two Pts required emergency deproning due to oropharyngeal bleeding and one due to sudden drop in ECMO flow. Otherwise, no major adverse events (ECMO cannula removal, accidental extubation or central vascular access removal) were documented. Conclusions: PP in VVECMO support therapy seems to be safe and is associated with improvement in lung mechanics and oxygenation. Further research is warranted to assess its effect on ECMO duration. Introduction: The objectives of this study are: first to describe the cases transferred to an ECMO referral center (Hospital Universitario 12 de Octubre), second to investigate characteristics before ECMO and while the patient was on ECMO, third to analyse the presence or not of complications secondary to transfer and cannulation and finally to analyse the ICU outcome. Methods: This is a prospective descriptive study of ECMO retrieval program done from November 1, 2020 to May 15, 2021. We analyzed baseline descriptive variables, severity Scores, variables before and during ECMO, prone position on ECMO, complications during cannulation and transfer. Finally ICU survival was examined. Results: Seventeen cases were accepted on the ECMO Retrieval program from November 1, 2020, to May 15, 2021. Thirteen (76%) of a total of 17 cases were male. Fifteen cases were accepted for emergency ECMO cannulation in the hospital of origin and transfer and 2 were accepted for conventional transfer and cannulation was done on the ECMO referral center. Basic characteristics of the cases were: median age of 48 (IQ 18) and IMC 31.2 (IQR 9.8). The etiology of SDRA was predominantly secondary to SARS-CoV-2 (COVID-19) infection, 16 cases of a total of 17 cases (94%). Lenght of non invasive ventilation and invasive ventilation before ECMO were 7.5 days (10.3 IQR) and 2 days (2.5 IQR) respectively and length of ICU admission before ECMO was 3 days (IQR 5). Severity scores were APACHE 8 (IQR 4), SOFA 4 (IQR 2.5), ELSO 3 (IQR 3). The cases where on ECMO Prone position was done on 9 cases (53%). Median days on ECMO were 13 days (IRQ 10). Succesfull weaning from ECMO were achieved on 9 cases (53%). No complications were seen on transfer or cannulation. ICU Survivors were 6 (35%). Conclusions: This is the first pilot study for ECMO retrieval in the region of Madrid, Spain. Despites high mortality in the context of COVID-19 pandemia, ECMO-MADRID retrieval program assures ECMO availability, and it allows to rescue severe ARDS cases in the whole region. Introduction: Patient-ventilator asynchrony (PVA) is difficult to detect consistently since it relies on visual inspection of the waveforms. However, the development of automatic detection methods is hampered by the lack of properly labelled ventilation data. One solution would be to utilize artificially generated data. In this study, we compared the performance of a detection method based on clinical data to a detection method based on simulated data. Methods: The detection method was based on a neural network that was trained to detect the start and end of the patient breathing efforts, as described in [1] . In our work, two different datasets were utilized to train the network. The first dataset consisted of clinical data and the second consisted of simulated data obtained from the model in [2] . The detection method was trained and tested in four different settings. As a baseline, only the clinical data was utilized. In the second to the fourth setting, the training data was extended with simulated data. Three different ratios of clinical to simulated data were utilized in each setting. To prevent overfitting the model was cross-validated (CV) with each patient being onefold of the cross-validation. Results: The quality of the detection for each of the trained networks was evaluated by comparing the detections to the ground truth, and the subsequent results are found in Table I . The results from Table I show that the inclusion of simulated data during the training resulted in a marginal improvement of detection quality. A maximum improvement of roughly 1% in both precision and recall was achieved with a mix-ratio of 1:2. In future research, further improvements in the simulations, e.g. including higher variability and more realistic triggering and cycling, can possibly lead to improved detection performance. Over the 10-year period, the observed mortality was similar to the APACHE-IV predicted mortality in high-volume centers, but was worse than predicted in low-volume centers (Fig. 1) . We demonstrated that ECMO in high-volume centers was associated with decreased mortality that closely reflected predicted outcomes. With the drastic increase in ECMO utilization worldwide, our data supports current international guidelines that delivery of ECMO should be consolidated to high-volume dedicated centers to improve patient outcomes of this expensive form of organ support. Introduction: Mortality remains high in patients with severe acute respiratory distress syndrome (ARDS) despite the use of veno-venous extracorporeal membrane oxygenation (VV ECMO). Understanding the differences between survivors and deceased patients is crucial for developing tomorrow's therapy. Methods: We report retrospective data of a single-center registry of patients with severe ARDS requiring VV ECMO support between 10/2010 and 04/2020. Vital parameters, laboratory values and blood gas analysis as well as the level of support of ECMO therapy, ventilator settings and catecholamine therapy of the first 10 days after ECMO cannulation were analyzed with regard to their association with survival. Results: A total of 283 patients with complete medical data could be analyzed (age 53 years, 66% male). Overall ECMO weaning and hospital survival rate were 52.8% and 44.8%, respectively. Survivors showed a lower level of ECMO support after day 2 (blood flow and sweep gas flow) and day 3 (fiO2, p < 0.05, Fig. 1 ). Pulmonary compliance and tidal volume were higher in survivors after day 1. Moreover, survivors showed a lower noradrenaline dosage in the first 8 days and a lower fluid balance in all 10 days. Interestingly, positive end-expiratory pressure, driving pressure, respiratory rate, mean arterial pressure, lactate and bilirubin showed no or no clinical significant association to survival. In this analysis of the first 10 days of ECMO therapy, there were major differences in the level of ECMO support, tidal volume and pulmonary compliance as well as fluid balance and required noradrenaline dosage between survivors and non survivors. Introduction: Mechanical ventilation for ARDS COVID-19 is cornerstone supportive therapy. While prolonged ventilation is typically needed increasing doses of benzodiazepines, propofol, opioids and NMBAs are addmnistered. Drug clearance is decreased and prolonged awakening, weaning and delirium is seen. Also, in some countries shortage of fentanyl, midazolam and propofol has been reported [1] . Sevoflurane has active metabolites and tachyphylaxis, tolerence or dependance has not been described. It has predictable and favorable pharmacokinetics with anti-inflammatory effects demonstrated in patients with ARDS. No data is available on using sevoflurane for sedation in COVID-19. We assessed feasibility of sevoflurane sedation in COVID-19 patients requiring mechanical ventilation. Methods: Thirty consecutive COVID-19 patients transferred to our ICU for advanced ventilatory support and/or rescue therapies were switched from midazolam and/or midazolam + propofol based sedation to sevofluran using Anaconda (Sedana Medical Sweden). Sedation depth was assessed using Richmond Agitation Sedation Scale (RASS) target -4 and Bispectral Index (BIS, Medtronic, US) target BIS 40-50. End expiratory sevoflurane concentration vas documented (Vamos, Dräger, Germany). All patients received continuous fentanyl and rocuronium. Results: In cohort of 30 invasively ventilated patients 71% were male with BMI 29 ± 9 and APACHE 17 ± 8. 18 (60%) patients received iNO (20 ppm) (Fig. 1) . Anaconda was placed in inspiratory limb in 3 (10%) patients. Conclusions: Sevoflurane via Anaconda provided adequate dept of sedation in all COVID-19 patients. Dose needed for adequate dept of sedation was higher than reported in other patient populations. Less infusion pump manipulation was needed during sevoflurane only sedation. No adverse events occurred during sevoflurane administration. Further research is warranted. Introduction: Feeding a patient the closer to his/her needs is a challenge in the intensive care unit (ICU), avoiding both under-or overfeeding and their associated complications and mortality [1] [2] [3] . But ICU patients have an unrepressed endogenous glucose production (EGP) [4, 5] , an energy source not considered by classical energy balance. This study aims at identifying clinically available variables predictive of EGP and gluconeogenesis (GNG), which otherwise need isotopic tracers. Methods: This exploratory study is based on the data from the Supplemental Parenteral Nutrition study 2 (SPN2) [5] , which measured EGP and GNG at days 4 and 10 in 23 ICU patients. The correlations between EGP and GNG and 83 potential clinical indicators were explored, using single-stage and multivariate analysis. Results: On single-stage analysis, the strongest correlations were norepinephrine dose at day 4 with GNG (R = 0.71; p = 0.0004), and at day 10, VO 2 with GNG (R = 0.59, P = 0.04), and VCO 2 with EGP (R = 0.85, p = 0.00003). Cumulated insulin dose between days 5 and 9 was correlated to EGP at day 10 (R = 0.55, p = 0.03). Our multivariate model could predict EGP at day 4 with an error coefficient (EC) between 7.8% and 23.4% (minimal and maximal error), and GNG at day with an EC of 18.5% and 29.9%. GNG at day 4 and EGP at day 10 could not be predicted with an EC < 40%. Conclusions: This preliminary study shows that GNG and EGP have different predictors on days 4 and 10; EGP is more correlated with the metabolic level, while GNG is dependent on external factors. Some variables could be identified to assess the magnitude of both values. Our results suggest that a robust model might be built, but require a prospective study including a larger number of patients. conventional pH measurement of aspirate (if obtained) and CO 2 detection using the DoubleCHEKTM device (https:// enter alacc esste ch. com). NGT location on CXR was also recorded. Users were asked to complete an evaluation form containing device experience questions and allowed free-text comments. Results: Evaluation of the device was completed in 29/30 (96.67%) of cases. Aspirates were obtained in 14/30 (46.67%) cases with 7/14 (50%), resulting in a pH of < 5.5 as measured by conventional pH strips. Of the 16/30 (53.33%) insertions yielding no aspirate, 3/16 (18.75%) were clinically located in the lungs. In these insertions, CO 2 was detected, the NGT was removed, and a second insertion attempt was successful as indicated by CXR or pH < 5.5. Of the 7/30 (23.33%) cases in which aspirates were obtained, but pH reading was > 5.5, six of seven (85.71%) CXRs showed that NGTs were in the stomach, and no CO 2 was detected with the DoubleCHEKTM device. Only 2/29 (6.8%) users would object to using the device in daily practice. Conclusions: Simultaneous pH and CO 2 detection is a promising method to avoid misplacement of NGTs. Difficulties in obtaining aspirates and high pH are common problems in NGT placement [1] . Further clinical trials are warranted to determine sensitivity and specifity of the technique compared to standard protocols and to evaluate the cost-saving potential. Introduction: In critical illness, increased glycaemic variability is associated with greater mortality and morbidity [1] and the relationship with the mode and timing of enteral nutrition (EN) delivery are unknown [2] . We assessed the effect of intermittent vs continuous EN delivery and delivery time on glycemic variability. Methods: Preliminary data of an active parallel, single-center, singleblinded, trial in non-diabetic ICU patients (age ≥ 18 y; receiving or eligible to receive nasogastric EN), who were randomized to 24 h of isocaloric EN delivered intermittently (INT: 6-hourly bolus, T1 = 8:00 h, T2 = 14:00 h, T3 = 20:00 h, T4 = 2:00 h) or continuously (CONT) were analyzed. Subcutaneous continuous glucose monitoring (DEXCOM G6) was used to assess glycemic variability (standard deviation; SD, coefficient of variation; CV, and mean absolute glucose concentrations; MAG) and 6 h postprandial blood glucose levels (area under curve; AUC) were calculated. Variables were compared between EN mode and over time. Data are expressed as mean ± SD. Results: Groups were not different at baseline (INT vs CONT: n = 11 vs 9; age: 49 ± 16 vs 55 ± 11 y; BMI: 31 ± 11 vs 32 ± 6 kg/m 2 ; APACHE II: 19 ± 9 vs 16 ± 5). Glycemic variability over 24 h (SD: 1.3 ± 0.6 vs 1.0 ± 0.5 mmol/l; CV: 17.8 ± 10.5 vs 14.2 ± 3.9%; MAG: 1.7 ± 0.8 vs 1.3 ± 0.3 mmol/l) did not differ between INT and CONT, respectively ( Fig. 1 ; all p > 0.05). In INT, postprandial peak glucose levels were higher at T4 (10.7 ± 2.3 mmol/L) than T1 (9.8 ± 2.2 mmol/l, p = 0.02) and T2 (9.5 ± 2.6 mmol/l, p = 0.01), while the postprandial rise in glucose did not differ between bolus times (all p > 0.05). Postprandial glucose AUC was higher in both T3 and T4 when compared to T1 and T2 (all p < 0.05). Conclusions: In critical illness, intermittent delivery of EN is likely not associated with increased glycaemic variability compared to continuous feeding and the glycemic response to intermittent EN appears to be increased at night. Only eating all was slightly lower by 5% in patients with an ICU stay whereas eating half, quarter or nothing was similar. Patients with a previous ICU stay had more than twice as often EN 13 vs 7 and 13 vs 4% in cohort 1 & 2 (p < 0.001) and PN 8 vs 4% in both cohorts. The OR for EN and PN was strongly affected by BMI, self-rated health and actual eating ( Fig. 1 Cohort 2). PN was not driven by a previous ICU stay in cohort 2. Patients with a previous ICU stay and eating nothing received EN or PN in 55% and 60% compared with 30% and 31% in those without ICU stay (p < 0.001). After an ICU stay, artificial nutrition is used twice as often than in patients without an ICU stay but patient appearance (BMI and subjective health) appears to be a strong independent factor. ward area 11.5% (n = 19). The pathology (P) related to CpHV < 7.2 was Cardiac P (28.5%, n = 47), sepsis (14.5%, n = 24), Respiratory P (14%, n = 23), Digestive (12%, n = 20) and other P (31% [1] . Here, we reflect on its evolution, evaluate feedback and assess whether it is still fit for purpose. Methods: The program is delivered as a mixture of lectures and practical workshops. It aims to introduce core critical care topics, helping to alleviate anxiety felt by new starters. Initially the attendees were new doctors, but it has since been expanded to include new nursing staff. The themes covered remain unchanged: mechanical ventilation, noninvasive ventilation, cardiac output monitoring, inotropes and vasopressors, sedation and delirium, renal replacement therapy, and airway management, but the content within each theme has been modified according to feedback from previous courses. This year, we have also had to make adjustments to enable smaller groups in line with covid social distancing advice. Attendees were sent a pre-and post-course questionnaire, asking them how strongly they agreed with certain statements using a Likert scale (1-strongly disagree, 5-strongly agree). Unpaired t-tests were used to compare pre-and post-course results, and these were in turn compared to data from previous courses. Results: Feedback from 2021 (Table 1 ) demonstrated that after the course, attendees felt significantly more prepared for ICU clinical work (mean pre-course score 2.47 (SD = 0.94), mean post-course score 3.03 (SD = 1.26), p < 0.01) and more knowledgeable (mean pre-course score 2.88 (SD = 0.96), mean post-course score 4.04 (SD = 0.56), p < 0.01). These findings were similar to previous courses. Conclusions: Feedback was consistently positive in all domains over all courses run since 2018. The program has improved novice knowledge and confidence in the basics of critical care, and the course is now multidisciplinary. Introduction: Every new admission to the intensive care unit (ICU) prompts a handover from the referring department to the ICU staff. This step in the patient pathway provides an opportunity for information to be lost and for patient care to be compromised. Mortality rates in intensive care have fallen over the last twenty years, however, 20% of patients admitted to an ICU will die during their admission [1] . Communication errors contribute to approximately two-thirds of notable clinical incidents; over half of these are related to a handover [2] . NICE have concluded that structured handovers can result in reduced mortality, reduced length of hospital stay and improvements in senior clinical staff and nurse satisfaction [3] . Methods: A checklist was created with doctors and nurses to review the information shared and to score each handover. This was relevant for handovers between all staff members. Information was gathered prospectively by directly observing 17 handovers on the ICU. Results: There is a notable discrepancy in the quality of handovers of new patients (Fig. 1) . This is true of handovers between doctors, nurses and a combination of the two. It is also true of all staff grades. Whilst a doctor may have reviewed the patient prior to their arrival, 41% (n = 7) of patients were not handed over to a doctor. The most commonly missed pieces of information were the patient's weight (96%, n = 16), their height (100%, n = 17), whether they had previously been admitted to an ICU (78%, n = 15) and whether they had any allergies (71%, n = 12). The handover of new patients to the ICU is often unstructured and information is missed. This is true for all staff members and grades, and for handovers from all hospital departments. Standardising handovers could improve their efficiency and effectiveness. Crit Care 2021, 25(Suppl 1):383 We aimed to compare the prevalence and severity of fatigue in survivors of COVID-19 versus non-COVID-19 critical illness, and to explore potential associations between baseline characteristics and worse recovery. Methods: We conducted a secondary analysis of two prospectively collected datasets. The population included was 92 patients who received invasive mechanical ventilation (IMV) with COVID-19, and 240 patients who received IMV with non-COVID-19 illness before the pandemic. Follow-up data were collected using self-reported questionnaires. The main outcome measures were self-reported fatigue severity and the prevalence of significant fatigue at 3-12-months post-hospital discharge. Results: COVID-19 IMV-patients were significantly younger with less prior comorbidity, and more males, than pre-pandemic IMV-patients. Introduction: The publication of large, rich, single patient level data sets has significantly propelled clinical research possibilities in the intensive care unit (ICU) and beyond. After publication of MIMIC-III, additional datasets have previously been released [1] [2] [3] [4] , thus warranting a comparison of their data completeness and richness to allow scientists to choose the most appropriate dataset(s) for their clinical problem. Methods: A systematic search of published and pre-print articles was performed to identify all publicly available, adult, critical care, patient level databases. Subsequently, databases were compared using a priori defined categories, such as demographics, patient characteristics and data richness. Results: A total of 4 ICU databases were identified (MIMIC-IV, eICU-CRD, AmsterdamUMCdb, HiRID). Number of unique patient admissions varied significantly between datasets, with eICU-CRD being the largest (> 130 K) and AmsterdamUMCdb the smallest (> 23 k). ICU mortality and intensity of treatment also varied, with eICU-CRD 28-day mortality rates and frequency of ventilation being lowest among the datasets. Frequency of laboratory values tended to be highest in MIMIC-IV, while frequency of vital signs was highest in AmsterdamUMCdb. Several high-quality ICU databases are currently available. The research question, and thus required sample size, presence of covariates and frequency of measurements, should inform which database to use. outcomes for illness severity or other potential confounders. Women were less likely than men to receive invasive mechanical ventilation (MV pooled OR = 0.83, 95% CI 0.77-0.89, I 2 = 90%) (Fig. 1 ) or renal replacement therapy (RRT pooled 0.79, 95% CI 0.70-0.90, I 2 = 76%) and had shorter mean length of stay in ICU than men (mean difference -0.24 days, 95% CI -0.37 to -0.12, I 2 = 90%). These findings persisted in a pre-specified sensitivity analysis excluding studies at high risk of bias. Women and men had similar mean duration of mechanical ventilation and hospital length of stay. Conclusions: Compared to men, women were less likely to receive mechanical ventilation or renal replacement therapy and had shorter admissions to the ICU. There is substantial heterogeneity and risk of bias in the existing literature, therefore further research is warranted. (OR = 1.24, 95% CI = 1.09, 1.41). Table 1 illustrates the performance of the model as a screening tool. Conclusions: Emergency hospital readmissions are common in this ICU survivor cohort. This simplistic model can be used as a screening tool at hospital discharge to identify patients at high risk of emergency hospital readmission. This allows risk stratification of need for outpatient support. Further consideration should be given to exploring modifiable risk factors for readmission to improve the cost-effectiveness and clinical utility of post-ICU outpatient care. Introduction: Old adults are the fastest-growing segment of the population in many developed countries [1] . Data paucity on the post-ICU outcomes in this population is perpetuated by the reluctance of physicians to admit very old patients (VOP) to the ICU [2, 3] . The aim of this study was to assess the characteristics and the short and longer-term outcomes of critically ill VOP. We included all patients aged 80 y/o and over admitted to the ICU of a large tertiary hospital in 2018. We collected patient demographics (including frailty scores) along with data on admission diagnoses, treatment escalation decisions, and mortality. Frailty scores were assigned based on admission functional status, using a 9-item clinical frailty scale (CSF) [4] . Results: A total of 191 patients with a median age of 84 (IQR 82-87 y/o) were included. More than half (51%) were frail and almost a quarter (23%) had a do-not-attempt-cardiopulmonary resuscitation (DNACPR) order in place before ICU admission. Most VOP were admitted emergently (93.7%), with a non-surgical diagnosis (78.5%). Details on the interventions undertaken in both groups are shown in Table 1 . In our cohort, the ICU mortality was 30.4% and the 1-year fatality rate 60.2%. Higher frailty was associated with lower ICU death (16.3% vs 45.2%, p < 0.001), but similar hospital and long-term mortality. Factors associated with non-survival at 1 year were higher SOFA scores (OR 1.2, 95%CI 1.001-1.4), DNACPR status on admission (OR 2.7, 95%CI 1.1-6.5), and non-surgical pathology (OR 3.5, 95%CI 1.5-8.8). Conclusions: Most of the VOP survived their ICU stay and almost 40% of them were alive at 1 year. Our results do not support ICU admission bias against this population. However, as we did not examine longterm sequelae, the burden of critical illness on functional outcomes could not be assessed. Wolters Kluwer Health/Lippincott Williams & Wilkins References 1 References 1 References 1 References 1 References 1 Reference 1. Queen Elizabeth Hospital Birmingham COVID-19 airway team P165 Diaphragmatic ultrasound in difficult weaning: monitoring of References 1 Observed mortality in hospital was 24% within 60 days. In Europe 39% of patients receive EN either alone or in combination with PN and 27% PN. One out of four patients are on oral nutrition whereas one out of seven receive EN or PN in addition to oral nutrition. Outside Europe more patients were on EN, PN was used about half as frequently and oral nutrition was more prevalent. The pReference for EN was independent of age, BMI and sex. EN became more prevalent with duration of ICU stay. Reason for ICU admission neurological and cardiac increased the preference for EN and abdominal reasons for PN. Americas and Asia preferred EN compared with both European regions. EN was more prevalent with increasing sever (abstract P196) Preferential use of enteral (OR < 1) or parenteral (OR > 1) nutrition in the nutritionDay cohort Introduction: The generation of an automated alert [1] in Laboratory Information System (LIS) addressed to the applicant after validation critical pH value (CpHV) < 7.2 would ease optimal clinical performance. Methods: Intervention study with Phase 1 or historical control from 1 / 2018 to 12 / 2018, including ward area and emergency patients > 14 years and CpHV < 7.2. Demographic, clinical and time variables were recorded in different clinical actions. The program used for data processing, descriptive and comparative statistical analysis was carried out with SPSS version 20.0, according to the nature of variables and study objectives. Project approved by the Ethics and Research Committee References 1. ICS. Guidelines for the Provision of Intensive Care Services, Version 2. ICS National Institute for Health and Care Excellence (UK) HiRID, a high time-resolution ICU dataset (version 1.1.1) We conducted a systematic search up to 03.02.2021 with terms related to COVID-19 and frail* in MEDLINE (via PubMed), EMBASE, Scopus, CENTRAL, and Web of Science. Studies reporting on frailty in COVID-19 patients were eligible. We compared in-hospital and 30-day mortality, LOH and ICU admission in frail and non-frail COVID-19 patients. Search, selection, data extraction and risk of bias (RoB) assessmentwere conducted in duplicate by two independent authors. The QUIPS tool was used for the RoB assessment. Odds ratios (OR) and weighted mean differences (WMD) were calculated with 95% confidence intervals (CI) using a random effect model. Heterogeneity was assessed using the I2and χ 2 tests. Results: From 1693 records, 27 were included in the qualitative and 21 in the quantitative synthesis. Clinical Frailty Scale (CFS) was used in 24 studies. We found that frail patients (CFS 5-9) compared to non-frail patients (CFS 1-4) have a higher risk for both in-hospital Quantitative synthesis for LOH was not feasible. Most results showed considerable heterogeneity. Most studies carried a high risk of bias. Conclusions: As determined by CFS, frailty is strongly associated with in-hospital and 30-day mortality; hence, investigating its use in decid 5%) pts needed tracheal intubation and 15 (7.1%) needed ECMO. 116 (54.7%) pts resulted MDR positive during their hospital stay. 28 day mortality was 21.2% and this was related to age and BMI (p < 0.05); global ICU mortality was 30.2 (p < 0.05 for age and sex) and hospital mortality was 34.4% (p < 0.05 for age, sex and BMI). ICU and hospital LOS were 18 (6-25) 31 (18-45) days; this latter was significantly related to BMI. Patients' outcome was significantly related to peak lymphocyte, lactate, fibrinogen and D-Dimer. Conclusions: Our second hit was tougher with higher morbidity and mortality. P213 How to protect the hospital from contamination: predictors of COVID-19 infection among emergency COVID-19 Committee, Mongi Slim Academic Hospital Mongi Slim Academic Hospital, Tunis, Tunisia Critical Care Epidemiological situation of the coronavirus in Belgium: daily report of national and international situation National Institute for Health and Care Excellence. COVID-19 Rapid Guideline: Critical Care Fig. 1 (abstract P216) PICS impairment co-occurrence precentages refer to frequency of each component of PICS (psychological, functional and cognitive impairment) and their concurrency in PICS patients Anesthesia Practice Consultants Trauma Research Institute, Spectrum Health, Grand Rapids, USA; 4 Trauma Research Institute & Acute Care Surgery and General Surgery, Spectrum Health P222 Limitation of life-sustaining treatment in critically ill patients admitted in ICU with SARS-CoV-2 pneumonia A. Estella 1 , M. Recuerda 2 , A. Garrino 3 , P. Bustelo 3 , C. De La Fuente 4 Intensive Care Unit, University Hospital Virgen Macarena Sevilla The authors are convinced that thrombolysis could be considered in asubgroup of patients with intermediate risk PE with tachycardia, lactatemia and left preload compromise, despite the absence of hypotension or shock. The project was financially supported by Infectopharm GmbH, Heppenheim, Germany. Investigation of the correlation between perioperative oxygen reserve index and peripheral oxygen saturation and partial arterial oxygen pressure values in patients undergoing hypotensive anesthesia H. Sarizeybek 1 , C. Balci 2 1 Anesthesiology, Zonguldak Public Hospital, Zonguldak, Turkey; 2 Anesthesiology and Reanimation, Kutahya Healty Science Un., Kutahya, Turkey Critical Care 2021, 25(Suppl 1): P164 Introduction: Excessive oxygen administration is known to cause absorption atelectasis during general anesthesia. There are concerns in using excessive oxygen during general anesthesia, the optimal fraction of inspired oxygen (FiO 2 ) for general anesthesia is not studied. Oxygen Reserve Index (ORI) is a new parameter for noninvasive monitoring [1] . In our study, we evaluate the correlation between ORI and the SpO 2 in underwent hypotensive anesthesia adults. Methods: Our study is between the ages of 20-60; Twenty-four patients who will undergo elective tympanoplasty-mastoidectomy by applying hypotensive anesthesia are included in Group 1, and 9 patients who will undergo laryngectomy-neck dissection without hypotensive anesthesia are included as Group 2. Results: There are 24 patients who have peroperative hyperoxic period in Group 1 and 5 of them were detected as hyperoxic with ORI (20.83%). In group 2, there are 8 patients who have hyperoxic period and 6 of them were detected as hyperoxic with ORI (75%).In our study, the value of ORI = 0 for the 150 mmHg value that we accept the safe PaO 2 limit has high specificity and sensitivity. Conclusions: In our study, although there was a significant relationship between PaO 2 and ORI in both groups. In order to benefit from the mentioned advantages in terms of clinical use of ORI, we think that larger clinical studies may be beneficial in patients receiving hypotensive anesthesia. Introduction: COVID-19 pandemic continues to affect millions worldwide, while the critical form of the disease requires ICU hospitalization to manage mainly respiratory failure. Our retrospective observational study aimed to test the hypothesis that there is a difference in mean values of oxygenation parameters on ICU admission day, like oxygenation index (PaO 2 /FiO 2 ) and oxygenation index over respiratory rate, among patients with confirmed critical COVID-19 infection who died and patients who survived ICU. Methods: During late 2020 to 2021, 69 patients indicated with the diagnosis of critical COVID-19 disease admitted to ICU served to our community hospital. Mean age 66.14 years, length of stay 10.75 days, days under mechanical ventilation 9.97. The patients separated into two groups. Group A involved all patients who survived ICU (17 pts) and group B all patients who died in ICU (52 pts). We looked for statistically significant differences between the medians values of two groups according to oxygenation parameters on the ICU admission day, performing unpaired t -test or Mann-Whitney Test according equal S.D.s assumption. Results: Results are shown in the Table. Conclusions: According to our data, there was a strong statistically significant difference detected between the mean values of two groups according to oxygenation parameters we measured, while the oxygenation index over respiratory rate proved to be the stronger. Our data suggest that the oxygenation disorder was not only the main impact of COVID-19 infection on the ICU admission day, but was so important that affected the ICU outcome as well. Introduction: ICU staff are aware that hypoxic patients with ARDs should be ventilated at 6 ml/kg. Hitting this target is difficult to achieve, even in protocolised research trials [1] . We have been monitoring the total time within the target 6 ml/kg PBW for patients with a P/F ratio < 200 for 18 months using this as an outcome measure to monitor iterative changes to improve adherence to this target. Here we report the results of a project determining whether heights are correctly measured and inputted into the ventilators. Methods: All patients who required ventilation for > 12 h were selected for this study during a five-week period in an ICU of a DGH. Data collected for each patient included: PBW, height on IntelliSpace Critical Care and Anaesthesia (ICCA), height in ventilator, measured height, tidal volume (ml/kg), P/F ratio and mode of ventilation. Results: Data were collected for 21 patients. 1 had no PBW inputted on the ventilator. 19.1% of patients (4/21,95% CI 5.5-41.9%) had PBW inputted incorrectly. 14.3% had ventilation heights significantly different to their actual height on ICCA (2/14, 95% CI 1.8-42.8%). 36.8% (7/19, 95% CI 16.3-61.6%) had a time delay of > 1 h between ventilation and recording their height on the ventilator. 23.8% (6/21, 95% CI 11.3-52.2%) had a tidal volume of > 6.0 ml/kg of PBW. The time we hit the 6 ml/kg target varies weekly with performance worst in weeks with patients on ventilators with a P/F < 200. This demonstrated that we are not consistently measuring patients correctly or inputting measurements promptly in the ventilator. This provides a great starting point for an education programme, the success of which can be monitored using the weekly outcome measure of % time < 6 ml/kg reported on the run chart above (Fig. 1) . Introduction: Protective ventilation parameters have been associated with better outcomes in patients with ARDS, however, ventilator power could be associated whit better outcomes. In this study, we analyzed the trend of the ventilatory parameters including the respiratory work and ventilatory power during the first four days of mechanical support in patients with ARDS due to COVID-19. Methods: Observational analytical retrospective study. We included ARDS patients due to COVID-19 with need of invasive mechanical ventilation support for at least four days, that were admitted in the intensive care units between March 2020 and 2021. We describe the trend of ventilatory parameters in the first four days and evaluate the association of these parameters trends with mortality. Results: Forty-nine patients meeting the inclusion criteria were analyzed, no significant difference was found in the ventilatory parameters of the surviving and non-surviving patients on the first day of mechanical ventilation support, meeting criteria for protective ventilation in both groups. The progression of ventilatory parameters during the first four days evidenced a significant increase in the energy delivered to the respiratory system in the no survivors patients compared with survivors patients, especially in the ventilator inspiratory power (4.82 vs 0.2 J/min) p: 0.04. There is a trend of increase of adjusted ventilator inspiratory power (8 vs 0.2 J/min/kg ideal body weight*10) ventilator work (0.18 vs -0.03 J) and adjusted ventilator work (0.3 vs 0 J/ kg ideal body weight*100). No significant difference was found in the trend of driving pressure over the first four days of support. Conclusions: More than the absolute value in the ventilatory parameters at the beginning of mechanical ventilation support, the trend to increase in the ventilator inspiratory power over the first days of mechanical support, could be better associated with mortality in ARDS patients due to COVID-19. Introduction: Mechanical ventilation (MV) has been associated with neuroinflammation. Microglia are key cells that initiate and control inflammation in the brain, behaving either as pro-inflammatory or anti-inflammatory cells. We investigated whether transvenous temporary diaphragm neurostimulation (TTDN) in synchrony with MV, a hybrid ventilation strategy, mitigates neuroinflammation. Methods: Thirty-one healthy juvenile pigs (4-5 months, 48-66 kg) with non-injured lungs were divided into four groups: MV only (MV group, n = 10), MV in association with diaphragm neurostimulation delivered either every other breath (TTDN50% + MV group, n = 8) or every breath (TTDN100% + MV group, n = 7) and never ventilated (NV group, n = 6). TTDN targeted a reduction in pressure-time product between 15 and 20%. Volume control MV was set to achieve and maintain a tidal volume of 8 ml/kg with a PEEP of 5 cmH2O. Hippocampus samples were harvested, and IBA-1 assay was used to stain microglia. Machine learning software classified microglia cells as either pro-inflammatory or anti-inflammatory based on cellular biometric characteristics. Data are expressed as median and interquartile range. The Kruskal-Wallis test and Dunn's multiple comparison test were used for statistical analysis. P values £0.05 were considered statistically significant. Results: Microglia percentages were dependent on TTDN dose. Differences in percentages of IBA-1-positive hippocampal cells were statistically significant between groups, p < 0.0001 ( Fig. 1) . Microglia from the TTDN100% + MV group had cellular characteristics statistically indistinguishable from the NV group. Conclusions: TTDN mitigates neuroinflammation after 50 h of MV. TTDN every breath results in microglia cellular characteristics similar to the NV group. Introduction: Although use of veno-venous extracorporeal membrane oxygenation (VV-ECMO) for ARDS is increasing worldwide, criteria for eligibility are not clear and use of ECMO for older patients is still debated. The primary objective of this meta-analysis and meta-regression was to determine whether mortality on VV-ECMO is affected by patient's age. We searched Pubmed for studies published between 2015 and 2019, using the keyword 'ECMO' . Only RCTs and observational studies on VV-ECMO with > 10 patients were included. Secondary analyses of large databases were excluded to avoid data duplication. We excluded records rated as 'poor' according to the NIH study quality assessment tools. Outcomes were ICU, hospital and 3-month mortality. The relationship between mean age and mortality was investigated with meta-regression [1] and results reported as regression coefficient (b) with 95% confidence interval. We included 63 studies (22 rated as 'good' , 41 'fair'). ICU mortality was available in 22 studies, hospital-mortality in 45 studies, and 3-month mortality in six studies. We found a strong association between mean age and ICU mortality (b = 0.021, 95%CI: 0.011-0.031, p < 0.001) (Fig. 1) . The sensitivity analysis (considering only 'good' studies) showed the same b coefficient but not a statistically significant relationship (b = 0.021, p = 0.124). Similar association was found for hospital-mortality (b = 0.014, 95%CI: 0.008-0.020, p < 0.001), confirmed by the sensitivity analysis (b = 0.020, 95%CI: 0.006 -0.033, p = 0.008). There was a positive association (although not statistically significant b = 0.015, p = 0.204) between mean age and 3-months mortality; 'good' rated studies were too few to perform sensitivity analysis. Our meta-regression shows that mortality on ECMO is independently influenced by the age of the patient. Further analyses are needed to determine whether an age cut-off exists, above which mortality increases unacceptably. Introduction: Extracorporeal membrane oxygenation (ECMO) is important in the management of severe cardiac and pulmonary dysfunction when conventional methods fail. To study the outcome of pregnant women with severe COVID-19 ARDS who required ECMO. Methods: All patients were pregnant, admitted with COVID-19 and received ECMO in the intensive care unit (ICU) at Jahra hospital from September 2020 to May 2021 were included in this study and followed prospectively.Results: Twenty-nine pregnant women were in the ICU, 18 needed invasive ventilation. Out of those 18 patients, 10 required invasive ventilation, followed by ECMO. One patient died after abortion during ECMO and 9 patients discharged home. The median age was 32 years (IQR, 27 to 40) and a median Acute Physiology and Chronic Health Evaluation II score was 27 (IQR, 23 to 30). The gestational age at delivery was 33 weeks (range, 22 to 36 weeks). The indications for ECMO were severe COVID-19 ARDS (n = 8). One patient had massive pulmonary embolism, requiring VA-ECMO and local thrombolysis. All patients were endotracheally intubated for a median of 3 days (IQR, 2 to 5 days) before starting ECMO. Four patients delivered while on ECMO. One patient died who had reduced right ventricular function and was managed with VA-ECMO, dobutamine, and noradrenaline. One patient aborted her fetus while on ECMO, and nine patients underwent CS. The nine patients recovered and were successfully weaned from the combination of early mechanical ventilation and ECMO.Conclusions: ECMO has been used successfully in pregnant women with severe COVID-19 and severe hypoxia in our ECMO center. The high maternal and fetal survival rates in this prospective observational study suggest that the benefits of managing maternal and fetal hypoxia due to COVID-19 with ECMO outweigh the potential risks. Results: Seventy-nine South African intensivists participated in the survey. 82% of respondents indicated severe patient burden and bed pressure. More than 90% of respondents indicated that they found it morally acceptable to administer sedation and analgesia despite the anticipated hastened death (Fig. 1 ). These intensivists go on to admit that bed pressure and financial constraints factor into their end-of-life care decision making. The moral arguments regarding hastening death and euthenasia is unearthed in the South African intensive care arena, as the results of the survey uncovers the strain of severe bed pressure and financial constraints faced by intensivits. These entities are admittedly factored into end-of-life decision-making, particularly in terms of sedation and analgesic practice, in which hastening death is viewed positively by this cohort. Introduction: Over-sedation is an important issue for critically ill patients, and has been associated with increased mortality and morbidity, including delirium. Patients with acute respiratory distress syndrome (ARDS) frequently require deep sedation and neuromuscular blockade to optimize mechanical ventilation. We assessed the incidence of over-sedation and delirium in COVID-19 and non COVID-19 patients and sought any differences between those with and without ARDS. Depth of sedation was monitored through use of continuous processed EEG. Delirium was evaluated through use of the CAM-ICU. The main outcomes were the incidence of over-sedation and delirium and the correlation between them in COVID-19 and non COVID-19 patients with and without ARDS. A total of 78 patients were included into the study, 38 of whom ad ARDS, 21 of whom had COVID-19 disease.The mean monitoring time for the COVID-19 and the non-COVID-19 patients was respectively 43 and 50 h. Thirty-eight (49%) of the total 78 patients fulfilled the criteria for over-sedation.Results: There was a statistically significant association between the incidence of delirium and over-sedation (OR 11.4, p < 0.001) and age (OR 1.04, p = 0.017) (Fig. 1 ). When adjusting for age, over-sedation was still significantly associated to delirium (OR 8.35, p = 0.002). COVID-19 patients showed a non-significant higher percentage of delirium (92.3% vs 63.4%, p = 0.076).Although non-significant, there was a higher incidence of over-sedation (60.5% vs 37.5%, p = 0.069), and delirium (84% vs 58.6%, p = 0.07) in ARDS patients.Conclusions: This study shows that, besides age, over-sedation represents an important risk factor for delirium in mechanically ventilated patients, and that over-sedation and delirium were more common in ARDS vs non ARDS patients. It supports the use of continuous EEGbased monitoring systems for the quantification of sedation depth and highlights the necessity for larger, randomized trials to verify whether monitoring the depth of sedation can improve outcome. , and thyroid-stimulating hormone (TSH) < 0.003 μIU/mL (normal range: 0.5-5.0). All patients exhibited abnormal tachycardia and altered mentation. The symptoms of the patients mostly included fever, nausea, and vomiting. The most common cause (83.3%) of the TS was self-interruption of the anti-thyroid drug which is used to treat hyperthyroidism. One case exhibited diabetic ketoacidosis with TS. The 28-day mortality of all patients was found to be 33.3%. Conclusions: TS needs an early diagnosis and an aggressive treatment with the appearance of its symptoms to prevent worsening of the condition. Additionally, efforts should be made to maximize patient compliance to anti-thyroid agents used for the treatment of such patients. We extracted data independently and in duplicate: mean age and illness severity of women and men, length of stay in ICU and hospital, use of and duration of mechanical ventilation and use of renal replacement therapy. We assessed risk of bias using the Newcastle-Ottawa scale and used a Dersimonian-Laird random effects model to calculate pooled odds ratios and mean differences between women and men. We identified 21 studies with a total of 545,538 participants (42.7% women). The study populations ranged from 246 to 261,255 participants (median 4420). Most studies were at high risk of bias in at least one domain, for example not adjusting treatment intensity Introduction: Minimally invasive surgery constituted the source for professional illnesses among surgeons due to ergonomic problems. The aim of this study was to investigate the impact of the box-trainer in applying ergonomic guidelines for minimally invasive surgery. Methods: Our study was a prospective, transversal, and evaluative study realized at the department of surgery, Mahmoud El Matri hospital, during the period between January 15 and February 15, 2020. Volunteered-surgical resident trainees were recruited for this study. Low-cost box-trainer was used. Evaluative score was calculated after peg transfer task in optimal ergonomic settings then in non-optimal ergonomic settings. The principal judgment criterion was the difference between the scores. Results: First-and second-year participants accounted for 57% of all participants. Ten participants (33%) had no experience with minimally invasive surgery simulation. Twenty-two participants (73%) weren't aware about ergonomic principles. None of the participants had experienced ergonomic-dedicated simulations in minimally invasive surgery. The mean score obtained after peg transfer in optimal ergonomic settings was 107.0 (extremes: 19 and 220) versus 54.8 (extremes: 0 and 191) in non-optimal ergonomic settings. The difference was 39.6 in median (extremes: 7.3 and 70.1) with a statistically significance. Multi variant analysis retained only the resident year as an independent factor associated to the accomplished scores after comparison of the scores reached by first-and second-year residents versus those of third-, fourth-, and fifth-year residents. The impact of the box-trainer was the awareness rise about the importance of ergonomics in minimally invasive surgery, the application of these concepts, and the work environmental enhancement allowing better security for both sanitary staff and patients. The average RMSLE for confirmed cases and fatalities of six modeling countries were 0.08 and 0.13 respectively. For Taiwan confirmed cases was much higher than modeling countries (0.26), whereas slightly increased in fatalities (0.18). The figure also showed that our model captured the systematic variation in number of new cases per day in Taiwan and estimate additional 181 MV were needed in peak day. Our results can be of help to indicate the time-varying trend of COVID-19 and assist management team to estimate dynamic demand of MV for different regions. The early warning to government can leave more time for public decision-making. Introduction: Since Feb 2020 Italy has been facing COVID-19 pandemic. After the tough but efficient first wave struggle, the Veneto Region in Italy faced a more difficult second surge. We aimed to describe the COVID-19 critically ill pts admitted to our hospital (AOUI of Verona) during the second wave. Methods: Prospective observational study of all COVID-19-confirmed critically ill pts, treated at our ICUs between 1 Oct 2020 to 2 Feb, 2021. Date of final follow-up was May 1, 2021. Demographic and daily clinical data were collected, including data on organ failure, management and outcome. Results: According to our treatment protocol, all pts received dexamethasone 6 mg/day,therapeutic anticoagulation with LMWH and were supplemented with Vit C and D. 212 pts were included in the analysis, the median age was 65 ± 11 years and 161 (76%) were male.164 (77%) had cardiovascular disorders,43 (20%) had diabetes, overall BMI was 28.7(26-31); 105(49.5%) pts received pre-hospital antibiotic therapy. 112 (53%) pts were admitted from an intermediate care medical ward while 18 (8.5%) were transferred from another hospital ICU. APACHE II and SOFA scores were 17 ± 8 and 9.4 ± 3.1; 171 (80.7%) pts had only respiratory failure, while 17.3% of them were on vasopressors upon ICU admission. CRP was 105 ± 43 mg/l, PCT was 1.6 ± 0.2 ng/ml; total CPK, LDH and D-dimer were 290 ± 20 U/l, As the COVID-19 pandemic increases, Tunisia, like other countries, is committed to reorganizing health structures, mainly emergency departments, which not only continue to provide care for non-COVID-19 patients but also manage an influx of suspected COVID-19 patients.The objective of our study was to identify predictors for COVID-19 infection and to avoid contamination of the hospital. Methods: This was a prospective, descriptive study, extending over two months (from 03/27/2020 to 05/26/2020). We included all patients consulting the emergency department, regardless of the reason. The predictive factors of a COVID-19 infection, confirmed by PCR or by a typical appearance on the chest CT scan were sought. We included 5241 patients. The sex ratio was 0.97. The mean age was 44.6 ± 18 years. Thirty-five percent of patients were smokers. The most common medical history in our patients was hypertension (23.9%), diabetes (19.5%), asthma (7.8%), and coronary artery disease (7.7%). The reasons for consultation were dominated by cough, dyspnea, nausea or vomiting, and fever, in 9.5, 8.5, 8.8, and 6.9% of cases respectively. The concept of exposure was observed in 3.1% of patients. The concept of contact with a suspected case was observed in 1.3% of patients, while contact with health personnel was observed in 6.3% of patients. Suspicion of covid 19 infections was found in 2.3% of patients. Eighty-nine percent of patients were managed in the emergency department. Independent predictors of COVID-19 infection in multivariate analysis were: fever (adjusted OR = 21.19, p < 0.01), breathing difficulties (adjusted OR = 16.49, p < 0.01), neoplasia (adjusted OR = 15.93, p < 0.025), and contact with health care personnel (adjusted OR = 5.78, p < 0.019). Conclusions: Identification of predictive factors for COVID-19 infection allows detection of suspect patients up on arrival at pre-triage and triage areas, allowing isolation while ensuring continuity of care for non-COVID-19patients. Introduction: In early spring, Belgium was struck hard by the COVID-19 pandemic, reporting one of the highest mortality rates in the world [1] . Our hospital, Ziekenhuis Oost-Limburg (ZOL), is situated in Limburg, which was the epicenter of the COVID-19 crisis in Belgium, reporting the highest infection rate of all Belgian provinces [2] . National guidelines concerning admission criteria on ICU of patients with a COVID-19 pneumonia were lacking. This is a single center retrospective analysis of patients that would be have been excluded from ICU according to the NHS COVID-19 decision support tool [3] . All patients admitted to the ICU with a confirmed COVID-19 pneumonitis from March to June 2020 were included in the analysis. Methods: Categorical data were represented as numbers and percentages. The distribution of continuous data was analyzed and represented as either mean ± SD or median and IQR. No data imputation was done as for all variables the missings were less than 15%. All p values were two-sided and considered significant when < 0.05. All analyses were performed with JMPsoftware version 15.0.0 (SAS Institute, Cary, NC, USA The WRSS demonstrated that anxiety, mental exhaustion, and feelings of isolation were maximum at peak census and lower at other times. Levels of CS, BO, and STS were high across the study period (Fig. 1) . Conclusions: HCW demonstrated stress levels that were temporally associated with COVID-19 patient census. > 70% of ICU HCW showed high levels of BO and STS throughout the pandemic while also maintaining a high level of CS. There is an urgent need to address stress in ICU HCW. Methods: Adherence targets were set at 90% for three core guideline aspects: 7-10 days of dexamethasone administration, lung protective ventilation (LPV), and microbiology investigations (HIV, sputum culture, urinary legionella). This was a retrospective audit, with data collected from patients admitted to QE ICUs between September to November 2020 the electronic Prescribing Information and Communications System (PICS) system. Data was analyzed using Excel. Results: A total of 88 patients were included. The only investigation that met the 90% target was HIV testing (100%). Sputum culture, urinary legionella and influenza swab did not meet the target (50%, 16% and 8% respectively). 83% (n = 73) of patients received dexamethasone for 7-10 days. Overall LPV adherence was 72%, with significant variation between sub-parameters (Fig. 1) . Conclusions: Only a subsection of the investigations aspect of this guideline (HIV tests, bloods, imaging) met our targets. The remaining microbiology investigations, dexamethasone therapy, and LPV compliance fell short. One contributing factor we identified was the lack of staff familiarization with the environment and clinical system. We produced a set of recommendations to minimise the impact of these human factors on guideline adherence. Conclusions: More than 50% of patients presented with persisting symptoms -predominantly fatigue-for > 1 month post-discharge and abnormal spirometry even if only 20% of patients had severe disease during hospitalization which correlated with higher post-discharge SARS-COV-2 IgG titers. to February 2020. Patients and parents were contacted by phone by a pediatric intensivist to fill out validated questionnaires (Pediatric Quality of Life Inventory, Hospital Anxiety and Depression Scale) and to measure the impact of the COVID-19 pandemic on access to medical care and extrafamilial support. Results: Fifty-five families were contacted between November and December 2020. Quality of life scores were 88.1 ± 16.9 and 83.8 ± 13.9 for physical and psychosocial aspects, respectively. Symptoms of anxiety and depression were detected in 23.6% and 3.6% of respondent parents, respectively. A significant proportion of families reported cancelled health appointment (65.5%) and medication access issues (12.7%). Twenty-five families (45.5%) reported a significant decrease in their familial financial incomes. Conclusions: PICU survivors and their families experience significant impact on medical care and familial organization during the COVID-19 pandemic. Introduction: Limitation of life-sustaining treatment (LLST) is a recommended practice to avoid futility in critically ill patients who do not improve the medical condition despite invasive treatment. In SARS-CoV-2, LLST during ICU admission has been scarcely studied. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.